10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2022

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________________ to ________________

Commission file number  000-22117

SILGAN HOLDINGS INC.

(Exact name of Registrant as specified in its charter)

Delaware		06-1269834
(State or other jurisdiction		(I.R.S. Employer
of incorporation or organization)		Identification No.)
4 Landmark Square
Stamford,	Connecticut	06901
(Address of principal executive offices)		(Zip Code)

(203) 975-7110

(Registrant's telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	SLGN	Nasdaq Global Select Market

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒   No ☐

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files).  Yes ☒   No ☐

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐   No ☒

As of April 30, 2022, the number of shares outstanding of the Registrant’s common stock was 110,800,407.

-1-

SILGAN HOLDINGS INC.
TABLE OF CONTENTS
	Page No.
Part I.  Financial Information	3
Item 1.    Financial Statements	3
Condensed Consolidated Balance Sheets at March 31, 2022 and 2021 and December 31, 2021	3
Condensed Consolidated Statements of Income for the three months ended March 31, 2022 and 2021	4
Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2022 and 2021	5
Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2022 and 2021	6
Condensed Consolidated Statements of Stockholders’ Equity for the three months ended March 31, 2022 and 2021	7
Notes to Condensed Consolidated Financial Statements	8
Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations	16
Item 3.    Quantitative and Qualitative Disclosures About Market Risk	22
Item 4.    Controls and Procedures	22
Part II.  Other Information	23
Item 6.    Exhibits	23
Signatures	24

-2-

Part I. Financial Information

Item 1. Financial Statements

SILGAN HOLDINGS INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in thousands)

	March 31, 2022		March 31, 2021		Dec. 31, 2021
	(unaudited)		(unaudited)
Assets
Current assets:
Cash and cash equivalents	$	259,564	$	190,131	$	631,439
Trade accounts receivable, net	852,876		738,088		711,332
Inventories	1,018,685		788,637		798,837
Prepaid expenses and other current assets	150,646		102,382		154,241
Total current assets	2,281,771		1,819,238		2,295,849
Property, plant and equipment, net	1,979,681		1,811,593		1,993,877
Goodwill	2,024,340		1,701,040		2,038,408
Other intangible assets, net	817,450		613,220		830,772
Other assets, net	607,168		496,381		611,940
	$	7,710,410	$	6,441,472	$	7,770,846
Liabilities and Stockholders’ Equity
Current liabilities:
Revolving loans and current portion of long-term debt	$	539,134	$	195,122	$	20,251
Trade accounts payable	850,532		629,494		1,133,318
Accrued payroll and related costs	109,096		105,745		109,279
Accrued liabilities	218,194		224,747		245,674
Total current liabilities	1,716,956		1,155,108		1,508,522
Long-term debt	3,445,633		3,163,292		3,772,926
Deferred income taxes	433,843		357,587		435,252
Other liabilities	475,739		489,129		491,450
Stockholders’ equity:
Common stock	1,751		1,751		1,751
Paid-in capital	328,201		309,635		325,448
Retained earnings	2,758,697		2,452,996		2,691,745
Accumulated other comprehensive loss	(244,642)		(291,806)		(259,828)
Treasury stock	(1,205,768)		(1,196,220)		(1,196,420)
Total stockholders’ equity	1,638,239		1,276,356		1,562,696
	$	7,710,410	$	6,441,472	$	7,770,846

See accompanying notes.

-3-

SILGAN HOLDINGS INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

For the three months ended March 31, 2022 and 2021

(Dollars and shares in thousands, except per share amounts)

(Unaudited)

	2022		2021
Net sales	$	1,441,886	$	1,238,110
Cost of goods sold	1,208,433		1,016,644
Gross profit	233,453		221,466
Selling, general and administrative expenses	100,011		97,379
Rationalization charges	1,379		10,357
Other pension and postretirement income	(11,329)		(12,819)
Income before interest and income taxes	143,392		126,549
Interest and other debt expense before loss on     early extinguishment of debt	29,349		26,423
Loss on early extinguishment of debt	1,481		883
Interest and other debt expense	30,830		27,306
Income before income taxes	112,562		99,243
Provision for income taxes	27,687		25,962
Net income	$	84,875	$	73,281
Earnings per share:
Basic net income per share	$	0.77	$	0.66
Diluted net income per share	$	0.76	$	0.66
Weighted average number of shares:
Basic	110,600		110,206
Effect of dilutive securities	793		824
Diluted	111,393		111,030

See accompanying notes.

-4-

 SILGAN HOLDINGS INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

For the three months ended March 31, 2022 and 2021

(Dollars in thousands)

(Unaudited)

	2022		2021
Net income	$	84,875	$	73,281
Other comprehensive income (loss), net of tax:
Changes in net prior service credit and actuarial losses	499		1,878
Change in fair value of derivatives	2,337		641
Foreign currency translation	12,350		(33,372)
Other comprehensive income (loss)	15,186		(30,853)
Comprehensive income	$	100,061	$	42,428

See accompanying notes.

-5-

 SILGAN HOLDINGS INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the three months ended March 31, 2022 and 2021

(Dollars in thousands)

(Unaudited)

	2022		2021
Cash flows provided by (used in) operating activities:
Net income	$	84,875	$	73,281
Adjustments to reconcile net income to net cash     provided by (used in) operating activities:
Depreciation and amortization	69,067		60,872
Rationalization charges	1,379		10,357
Stock compensation expense	4,879		5,010
Loss on early extinguishment of debt	1,481		883
Other changes that provided (used) cash, net of effects from acquisitions:
Trade accounts receivable, net	(141,113)		(103,549)
Inventories	(222,137)		(118,132)
Trade accounts payable	(29,881)		(59,825)
Accrued liabilities	(23,291)		(32,062)
Other, net	(12,660)		(8,983)
Net cash used in operating activities	(267,401)		(172,148)
Cash flows provided by (used in) investing activities:
Purchase of businesses, net of cash acquired	(1,333)		—
Capital expenditures	(68,491)		(68,764)
Other, net	(203)		402
Net cash used in investing activities	(70,027)		(68,362)
Cash flows provided by (used in) financing activities:
Borrowings under revolving loans	544,624		170,457
Repayments under revolving loans	(24,408)		(31,310)
Proceeds from issuance of long-term debt	—		499,725
Repayments of long-term debt	(300,000)		(500,000)
Changes in outstanding checks - principally vendors	(225,863)		(84,216)
Dividends paid on common stock	(18,722)		(16,055)
Debt issuance costs	—		(4,633)
Repurchase of common stock	(11,474)		(8,275)
Net cash (used in) provided by financing activities	(35,843)		25,693
Effect of exchange rate changes on cash and cash equivalents	1,396		(4,533)
Cash and cash equivalents:
Net decrease	(371,875)		(219,350)
Balance at beginning of year	631,439		409,481
Balance at end of period	$	259,564	$	190,131
Interest paid, net	$	33,116	$	31,655
Income taxes paid, net	6,718		15,297

See accompanying notes.

-6-

SILGAN HOLDINGS INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

For the three months ended March 31, 2022 and 2021

(Dollars and shares in thousands, except per share amounts)

(Unaudited)

	2022		2021
Common stock - shares outstanding
Balance at beginning of period	110,410		110,057
Net issuance of treasury stock for vested restricted stock units	390		329
Balance at end of period	110,800		110,386
Common stock - par value
Balance at beginning and end of period	$	1,751	$	1,751
Paid-in capital
Balance at beginning of period	325,448		306,363
Stock compensation expense	4,879		5,010
Net issuance of treasury stock for vested restricted stock units	(2,126)		(1,738)
Balance at end of period	328,201		309,635
Retained earnings
Balance at beginning of period	2,691,745		2,395,395
Net income	84,875		73,281
Dividends declared on common stock	(17,923)		(15,680)
Balance at end of period	2,758,697		2,452,996
Accumulated other comprehensive loss
Balance at beginning of period	(259,828)		(260,953)
Other comprehensive income (loss)	15,186		(30,853)
Balance at end of period	(244,642)		(291,806)
Treasury stock
Balance at beginning of period	(1,196,420)		(1,189,683)
Net issuance of treasury stock for vested restricted stock units	(9,348)		(6,537)
Balance at end of period	(1,205,768)		(1,196,220)
Total stockholders' equity	$	1,638,239	$	1,276,356
Dividends declared on common stock per share	$	0.16	$	0.14

See accompanying notes.

-7-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at March 31, 2022 and 2021 and for the

three months then ended is unaudited)

Note 1.               Significant Accounting Policies

Basis of Presentation. The accompanying unaudited condensed consolidated financial statements of Silgan Holdings Inc., or Silgan, have been prepared in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the accompanying financial statements include all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation. The results of operations for any interim period are not necessarily indicative of the results of operations for the full year.

The Condensed Consolidated Balance Sheet at December 31, 2021 has been derived from our audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.

You should read the accompanying condensed consolidated financial statements in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2021.

Note 2.               Revenue

The following tables present our revenues disaggregated by reportable segment and geography as they best depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. Revenues by segment for the three months ended March 31 were as follows:

	2022		2021
	(Dollars in thousands)
Dispensing and Specialty Closures	$	597,927	$	509,352
Metal Containers	650,726		554,081
Custom Containers	193,233		174,677
	$	1,441,886	$	1,238,110

Revenues by geography for the three months ended March 31 were as follows:

	2022		2021
	(Dollars in thousands)
North America	$	1,086,224	$	898,402
Europe and other	355,662		339,708
	$	1,441,886	$	1,238,110

Our contract assets primarily consist of unbilled accounts receivable related to over time revenue recognition and were $99.1 million, $86.4 million, and $78.2 million as of March 31, 2022 and 2021 and December 31, 2021, respectively. Unbilled receivables are included in trade accounts receivable, net on our Condensed Consolidated Balance Sheets.

-8-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at March 31, 2022 and 2021 and for the

three months then ended is unaudited)

Note 3.               Rationalization Charges

We continually evaluate cost reduction opportunities across each of our segments, including rationalizations of our existing facilities through plant closings and downsizings. We use a disciplined approach to identify opportunities that generate attractive cash returns. Rationalization charges by segment for the three months ended March 31 were as follows:

	2022		2021
	(Dollars in thousands)
Dispensing and Specialty Closures	$	—	$	5,231
Metal Containers	1,274		5,021
Custom Containers	105		105
	$	1,379	$	10,357

Activity in reserves for our rationalization plans were as follows:

	Employee Severance and Benefits		Plant Exit Costs		Non-Cash Asset Write-Down		Total
	(Dollars in thousands)
Balance at December 31, 2021	$	41,090	$	157	$	—	$	41,247
Charged to expense	621		733		25		1,379
Utilized and currency translation	(1,839)		(702)		(25)		(2,566)
Balance at March 31, 2022	$	39,872	$	188	$	—	$	40,060

Non-cash asset write-downs were the result of comparing the carrying value of certain production related assets to their fair value using estimated future discounted cash flows, a Level 3 fair value measurement (see Note 7 for information regarding a Level 3 fair value measurement).

Rationalization reserves as of March 31, 2022 were recorded in our Condensed Consolidated Balance Sheet as accrued liabilities of $4.8 million and other liabilities of $35.3 million. Excluding the impact of our withdrawal from the Central States, Southeast and Southwest Areas Pension Plan, or the Central States Pension Plan, in 2019, remaining expenses and cash expenditures for our rationalization plans are expected to be $0.6 million and $2.2 million, respectively. Remaining expenses for the accretion of interest for the withdrawal liability related to the Central States Pension Plan are expected to average approximately $1.0 million per year and be recognized annually through 2040, and remaining cash expenditures for the withdrawal liability related to the Central States Pension Plan are expected to be approximately $3.1 million annually through 2040.

-9-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at March 31, 2022 and 2021 and for the

three months then ended is unaudited)

Note 4.               Accumulated Other Comprehensive Loss

Accumulated other comprehensive loss is reported in our Condensed Consolidated Statements of Stockholders’ Equity.  Amounts included in accumulated other comprehensive loss, net of tax, were as follows:

 

	Unrecognized Net Defined Benefit Plan Costs		Change in Fair Value of Derivatives		Foreign Currency Translation		Total
	(Dollars in thousands)
Balance at December 31, 2021	$	(119,474)	$	(2,327)	$	(138,027)	$	(259,828)
Other comprehensive income before reclassifications	—		2,018		12,350		14,368
Amounts reclassified from accumulated other     comprehensive loss	499		319		—		818
Other comprehensive income	499		2,337		12,350		15,186
Balance at March 31, 2022	$	(118,975)	$	10	$	(125,677)	$	(244,642)

The amounts reclassified to earnings from the unrecognized net defined benefit plan costs component of accumulated other comprehensive loss for the three months ended March 31, 2022 were net (losses) of $(0.7) million, excluding an income tax benefit of $0.2 million. These net (losses) consisted of amortization of net actuarial (losses) of $(1.1) million and amortization of net prior service credit of $0.4 million. Amortization of net actuarial losses and net prior service credit was recorded in other pension and postretirement income in our Condensed Consolidated Statements of Income. See Note 9 for further information.

The amounts reclassified to earnings from the change in fair value of derivatives component of accumulated other comprehensive loss for the three months ended March 31, 2022 were not significant.

Other comprehensive loss before reclassifications related to foreign currency translation for the three months ended March 31, 2022 consisted of (i) foreign currency gains related to translation of quarter end financial statements of foreign subsidiaries utilizing a functional currency other than the U.S. dollar of $3.0 million, (ii) foreign currency gains related to intra-entity foreign currency transactions that are of a long-term investment nature of $0.8 million, and (iii) foreign currency gains related to our net investment hedges of $11.3 million, excluding an income tax (provision) of $(2.7) million. See Note 7 for further discussion.

Note 5.               Inventories

Inventories consisted of the following: 

	March 31, 2022		March 31, 2021		Dec. 31, 2021
	(Dollars in thousands)
Raw materials	$	295,713	$	263,580	$	394,102
Work-in-process	263,878		167,137		157,406
Finished goods	607,087		452,553		394,378
Other	14,787		14,955		15,731
	1,181,465		898,225		961,617
Adjustment to value inventory at cost on the LIFO method	(162,780)		(109,588)		(162,780)
	$	1,018,685	$	788,637	$	798,837

-10-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at March 31, 2022 and 2021 and for the

three months then ended is unaudited)

Note 6.               Long-Term Debt

Long-term debt consisted of the following: 

	March 31, 2022		March 31, 2021		Dec. 31, 2021
	(Dollars in thousands)
Bank debt
Bank revolving loans	$	508,000	$	137,000	$	—
U.S. term loans	1,000,000		400,000		1,000,000
Other foreign bank revolving and term loans	50,014		60,030		38,862
Total bank debt	1,558,014		597,030		1,038,862
4¾% Senior Notes	—		300,000		300,000
3¼% Senior Notes	723,190		763,945		739,180
4⅛% Senior Notes	600,000		600,000		600,000
2¼% Senior Notes	556,300		587,650		568,600
1.4% Senior Secured Notes	500,000		500,000		500,000
Finance leases	67,714		33,936		68,730
Total debt - principal	4,005,218		3,382,561		3,815,372
Less unamortized debt issuance costs and debt discount	20,451		24,147		22,195
Total debt	3,984,767		3,358,414		3,793,177
Less current portion	539,134		195,122		20,251
	$	3,445,633	$	3,163,292	$	3,772,926

At March 31, 2022, the current portion of long-term debt consisted of $508.0 million of bank revolving loans under our amended and restated senior secured credit facility, as amended, or the Credit Agreement, $28.4 million of other foreign bank revolving and term loans and $2.7 million of finance leases.

On March 28, 2022, we redeemed all $300.0 million aggregate principal amount of our outstanding 4¾% Senior Notes due 2025, or the 4¾% Notes, at a redemption price of 100 percent of their principal amount plus accrued and unpaid interest to the redemption date. We funded this redemption with revolving loan borrowings under the Credit Agreement and cash on hand. As a result of this redemption, we recorded a pre-tax charge for the loss on early extinguishment of debt of $1.5 million during the first quarter of 2022 for the write-off of unamortized debt issuance costs.

-11-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at March 31, 2022 and 2021 and for the

three months then ended is unaudited)

Note 7.               Financial Instruments

The financial instruments recorded in our Condensed Consolidated Balance Sheets include cash and cash equivalents, trade accounts receivable, trade accounts payable, debt obligations and swap agreements. Due to their short-term maturity, the carrying amounts of trade accounts receivable and trade accounts payable approximate their fair market values. The following table summarizes the carrying amounts and estimated fair values of our other financial instruments at March 31, 2022:

	Carrying Amount		Fair Value
	(Dollars in thousands)
Assets:
Cash and cash equivalents	$	259,564	$	259,564
Liabilities:
Bank debt	$	1,558,014	$	1,558,014
3¼% Senior Notes	723,190		721,671
4⅛% Senior Notes	599,229		575,280
2¼% Senior Notes	556,300		507,624
1.4% Senior Secured Notes	499,784		456,550

Fair Value Measurements

GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). GAAP classifies the inputs used to measure fair value into a hierarchy consisting of three levels. Level 1 inputs represent unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 inputs represent unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability. Level 3 inputs represent unobservable inputs for the asset or liability. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

Financial Instruments Measured at Fair Value

The financial assets and liabilities that were measured on a recurring basis at March 31, 2022 consisted of our cash and cash equivalents and derivative instruments. We measured the fair value of cash and cash equivalents using Level 1 inputs. We measured the fair value of our derivative instruments using the income approach. The fair value of our derivative instruments reflects the estimated amounts that we would pay or receive based on the present value of the expected cash flows derived from market interest rates and prices. As such, these derivative instruments were classified within Level 2.

Financial Instruments Not Measured at Fair Value

Our bank debt, 3¼% Senior Notes, 4⅛% Senior Notes, 2¼% Senior Notes and 1.4% Senior Secured Notes were recorded at historical amounts in our Condensed Consolidated Balance Sheets, as we have not elected to measure them at fair value. We measured the fair value of our variable rate bank debt using the market approach based on Level 2 inputs. Fair values of the 3¼% Senior Notes, 4⅛% Senior Notes, 2¼% Senior Notes and 1.4% Senior Secured Notes were estimated based on quoted market prices, a Level 1 input.

Derivative Instruments and Hedging Activities

Our derivative financial instruments were recorded in the Condensed Consolidated Balance Sheets at their fair values. Changes in fair values of derivatives are recorded in each period in earnings or comprehensive income, depending on whether a derivative is designated as part of a hedge transaction and, if it is, the type of hedge transaction.

-12-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at March 31, 2022 and 2021 and for the

three months then ended is unaudited)

We utilize certain derivative financial instruments to manage a portion of our interest rate and natural gas cost exposures. We generally limit our use of derivative financial instruments to interest rate and natural gas swap agreements. We do not engage in trading or other speculative uses of these financial instruments. For a financial instrument to qualify as a hedge, we must be exposed to interest rate or price risk, and the financial instrument must reduce the exposure and be designated as a hedge. Financial instruments qualifying for hedge accounting must maintain a high correlation between the hedging instrument and the item being hedged, both at inception and throughout the hedged period.

We also utilize certain internal hedging strategies to minimize our foreign currency exchange rate risk. Net investment hedges that qualify for hedge accounting result in the recognition of foreign currency gains or losses, net of tax, in accumulated other comprehensive loss. 

Interest Rate Swap Agreements

We have entered into two U.S. dollar interest rate swap agreements, each for $50.0 million notional principal amount, to manage a portion of our exposure to interest rate fluctuations. These agreements have a fixed rate of 2.878 percent and mature on March 24, 2023. The difference between amounts to be paid or received on our interest rate swap agreements is recorded in interest and other debt expense in our Condensed Consolidated Statements of Income and was not significant for the three months ended March 31, 2022. These agreements are with a financial institution which is expected to fully perform under the terms thereof. The total fair value of our interest rate swap agreements in effect at March 31, 2022 was not significant.

Natural Gas Swap Agreements

We have entered into natural gas swap agreements to manage a portion of our exposure to fluctuations in natural gas prices. The difference between amounts to be paid or received on our natural gas swap agreements is recorded in cost of goods sold in our Condensed Consolidated Statements of Income and was not significant for the three months ended March 31, 2022. These agreements are with a financial institution which is expected to fully perform under the terms thereof. The total fair value of our natural gas swap agreements in effect at March 31, 2022 was not significant.

Foreign Currency Exchange Rate Risk

In an effort to minimize our foreign currency exchange rate risk, we have financed acquisitions of foreign operations primarily with borrowings denominated in Euros. In addition, where available, we have borrowed funds in local currency or implemented certain internal hedging strategies to minimize our foreign currency exchange rate risk related to foreign operations, including net investment hedges related to the 3¼% Senior Notes which are Euro denominated. Foreign currency gains related to our net investment hedges included in accumulated other comprehensive loss for the three months ended March 31, 2022 were $11.3 million.

Note 8.               Commitments and Contingencies

A competition authority in Germany commenced an antitrust investigation in 2015 involving the industry association for metal packaging in Germany and its members, including our metal closures and metal container subsidiaries in Germany. At the end of April 2018, the European Commission commenced an antitrust investigation involving the metal packaging industry in Europe including our metal closures and metal container subsidiaries, which should effectively close out the investigation in Germany. Given the current stage of the investigation, we cannot reasonably assess what actions may result from these investigations or estimate what costs we may incur as a result thereof.

We are a party to other legal proceedings, contract disputes and claims arising in the ordinary course of our business. We are not a party to, and none of our properties are subject to, any pending legal proceedings which could have a material adverse effect on our business or financial condition.

-13-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at March 31, 2022 and 2021 and for the

three months then ended is unaudited)

Note 9.               Retirement Benefits

The components of the net periodic pension benefit credit for the three months ended March 31 were as follows:

	2022		2021
	(Dollars in thousands)
Service cost	$	3,300	$	3,788
Interest cost	5,159		4,354
Expected return on plan assets	(17,314)		(19,848)
Amortization of prior service cost	55		58
Amortization of actuarial losses	1,155		3,026
Net periodic benefit credit	$	(7,645)	$	(8,622)

The components of the net periodic other postretirement benefit credit for the three months ended March 31 were as follows:

	2022		2021
	(Dollars in thousands)
Service cost	$	25	$	28
Interest cost	109		95
Amortization of prior service credit	(416)		(456)
Amortization of actuarial gains	(77)		(48)
Net periodic benefit credit	$	(359)	$	(381)

Note 10.               Income Taxes

Silgan and its subsidiaries file U.S. Federal income tax returns, as well as income tax returns in various states and foreign jurisdictions. The Internal Revenue Service, or IRS, has completed its review of the 2020 tax year with no change to our filed federal income tax return. We have been accepted into the Compliance Assurance Program for the 2021 and 2022 tax years which provides for the review by the IRS of tax matters relating to our tax return prior to filing.

Note 11.               Treasury Stock

On March 4, 2022, our Board of Directors authorized the repurchase by us of up to an aggregate of $300.0 million of our common stock by various means from time to time through and including December 31, 2026. We did not repurchase any shares of our common stock pursuant to this authorization during the three months ended March 31, 2022.

During the first three months of 2022, we issued 667,004 treasury shares which had an average cost of $3.19 per share for restricted stock units that vested during the period. In accordance with the Silgan Holdings Inc. Amended and Restated 2004 Stock Incentive Plan, we repurchased 276,826 shares of our common stock at an average cost of $41.45 to satisfy minimum employee withholding tax requirements resulting from the vesting of such restricted stock units.

We account for treasury shares using the first-in, first-out (FIFO) cost method. As of March 31, 2022, 64,312,089 shares of our common stock were held in treasury.

-14-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at March 31, 2022 and 2021 and for the

three months then ended is unaudited)

Note 12.             Stock-Based Compensation

We currently have one stock-based compensation plan in effect under which we have issued options and restricted stock units to our officers, other key employees and outside directors. During the first three months of 2022, 409,900 restricted stock units were granted to certain of our officers and other key employees. The fair value of these restricted stock units at the grant date was $17.0 million, which is being amortized ratably over the respective vesting period from the grant date.

Note 13.             Segment Information

Reportable segment information for the three months ended March 31 was as follows:

	Dispensing and Specialty Closures		Metal Containers		Custom Containers		Corporate		Total
	(Dollars in thousands)
Three Months Ended March 31, 2022
Net sales	$	597,927	$	650,726	$	193,233	$	—	$	1,441,886
Depreciation and amortization(1)	36,619		21,064		9,883		42		67,608
Rationalization charges	—		1,274		105		—		1,379
Segment income	87,313		38,009		24,694		(6,624)		143,392
Three Months Ended March 31, 2021
Net sales	$	509,352	$	554,081	$	174,677	$	—	$	1,238,110
Depreciation and amortization(1)	28,890		21,249		9,373		39		59,551
Rationalization charges	5,231		5,021		105		—		10,357
Segment income	65,645		45,614		24,486		(9,196)		126,549

_____________

(1)Depreciation and amortization excludes amortization of debt discount and debt issuance costs of $1.5 million and $1.3 million for the three months ended March 31, 2022 and 2021, respectively.

Total segment income is reconciled to income before income taxes for the three months ended March 31 as follows:

	2022		2021
	(Dollars in thousands)
Total segment income	$	143,392	$	126,549
Interest and other debt expense	30,830		27,306
Income before income taxes	$	112,562	$	99,243

Sales and segment income of our metal containers segment and of part of our dispensing and specialty closures segment are dependent, in part, upon the vegetable and fruit harvests in the United States and, to a lesser extent, in a variety of national growing regions in Europe. The size and quality of these harvests varies from year to year, depending in large part upon the weather conditions in applicable regions. Because of the seasonality of the harvests, we have historically experienced higher unit sales volume in the third quarter of our fiscal year and generated a disproportionate amount of our annual segment income during that quarter.

-15-

Item 2.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Statements included in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this Quarterly Report on Form 10-Q that are not historical facts are “forward-looking statements” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and Securities Exchange Act of 1934, as amended.  Such forward-looking statements are made based upon management’s expectations and beliefs concerning future events impacting us and therefore involve a number of uncertainties and risks, including, but not limited to, those described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and in our other filings with the Securities and Exchange Commission.  As a result, the actual results of our operations or our financial condition could differ materially from those expressed or implied in these forward-looking statements.

General

We are a leading manufacturer of sustainable rigid packaging solutions for consumer goods products.  We currently produce dispensing and specialty closures for food, beverage, health care, garden, home, personal care, fragrance and beauty products; steel and aluminum containers for human and pet food and general line products; and custom designed plastic containers for personal care, food, health care, pharmaceutical, household and industrial chemical, pet food and care, agricultural, automotive and marine chemical products. We are a leading worldwide manufacturer of dispensing and specialty closures, a leading manufacturer of metal containers in North America and Europe, and a leading manufacturer of custom containers in North America for a variety of markets, including the personal care, food, health care and household and industrial chemical markets.

Our objective is to increase shareholder value by efficiently deploying capital and management resources to grow our business, reduce operating costs and build sustainable competitive positions, or franchises, and to complete acquisitions that generate attractive cash returns.  We have grown our net sales and income from operations largely through acquisitions but also through internal growth, and we continue to evaluate acquisition opportunities in the consumer goods packaging market.  If acquisition opportunities are not identified over a longer period of time, we may use our cash flow to repay debt, repurchase shares of our common stock or increase dividends to our stockholders or for other permitted purposes.

-16-

RESULTS OF OPERATIONS

The following table sets forth certain unaudited income statement data expressed as a percentage of net sales for the three months ended March 31:

	2022		2021
Net sales
Dispensing and Specialty Closures	41.5	%	41.1	%
Metal Containers	45.1		44.8
Custom Containers	13.4		14.1
Consolidated	100.0		100.0
Cost of goods sold	83.8		82.1
Gross profit	16.2		17.9
Selling, general and administrative expenses	7.0		7.9
Rationalization charges	0.1		0.8
Other pension and postretirement income	(0.8)		(1.0)
Income before interest and income taxes	9.9		10.2
Interest and other debt expense	2.1		2.2
Income before income taxes	7.8		8.0
Provision for income taxes	1.9		2.1
Net income	5.9	%	5.9	%

Summary unaudited results of operations for the three months ended March 31 are provided below.

	2022		2021
	(dollars in millions)
Net sales
Dispensing and Specialty Closures	$	597.9	$	509.3
Metal Containers	650.7		554.1
Custom Containers	193.3		174.7
Consolidated	$	1,441.9	$	1,238.1
Segment income
Dispensing and Specialty Closures (1)	$	87.3	$	65.7
Metal Containers (2)	38.0		45.6
Custom Containers (3)	24.7		24.5
Corporate	(6.6)		(9.2)
Consolidated	$	143.4	$	126.6

(1) Includes rationalization charges of $5.2 million for the three months ended March 31, 2021.

(2) Includes rationalization charges of $1.3 million and $5.0 million for the three months ended March 31, 2022 and 2021, respectively.

(3) Includes rationalization charges of $0.1 million for each of the three months ended March 31, 2022 and 2021.

Three Months Ended March 31, 2022 Compared with Three Months Ended March 31, 2021

Overview.  Consolidated net sales were $1.44 billion in the first quarter of 2022, a 16.5 percent increase as compared to the first quarter of 2021 primarily due to higher average selling prices due to the pass through of higher raw material and other inflationary costs across all segments, higher unit volumes in the dispensing and specialty closures segment including from acquisitions, and a more favorable mix of products sold in the custom containers segment, partially offset by lower unit volumes and a higher percentage of smaller cans sold in the metal containers segment, lower volumes in the custom containers segment and the impact from unfavorable foreign currency translation. Income before interest and income taxes for the first quarter of 2022 was $143.4 million, a $16.8 million increase as compared to the same period in 2021 primarily due to the

-17-

favorable impact in the current year period from the delayed pass through of lower resin costs as compared to the unfavorable impact in the prior year period from the delayed pass through of higher resin costs in both the dispensing and specialty closures and custom containers segments, strong manufacturing performance and operating efficiencies, higher unit volumes in the dispensing and specialty closures segment and lower rationalization charges, partially offset by inflation in manufacturing costs, lower volumes in the metal containers and custom containers segments, the mix impact of more smaller cans sold in the metal containers segment and the impact of unfavorable foreign currency translation. Results for the first quarters of 2022 and 2021 included rationalization charges of $1.4 million and $10.3 million, respectively. Results for the first quarters of 2022 and 2021 also included a loss on early extinguishment of debt of $1.5 million and $0.9 million, respectively. Net income for the first quarter of 2022 was $84.9 million as compared to $73.3 million for the same period in 2021.  Net income per diluted share for the first quarter of 2022 was $0.76 as compared to $0.66 for the same period in 2021.

Net Sales.  The $203.8 million increase in consolidated net sales in the first quarter of 2022 as compared to the first quarter of 2021 was the result of higher net sales across all the segments.

Net sales for the dispensing and specialty closures segment increased $88.6 million, or 17.4 percent, in the first quarter of 2022 as compared to the same period in 2021. This increase was primarily the result of higher average selling prices due to the pass through of higher raw material and other inflationary costs and higher unit volumes of approximately eight percent, partially offset by the impact of unfavorable foreign currency translation of approximately $15 million. The increase in unit volumes was principally the result of the inclusion of the recent acquisitions and higher volumes for beauty and fragrance products, partially offset by a decrease in volumes for hygiene and home cleaning products which continued to be impacted by an inventory correction throughout the supply chain, and for metal closures as a result of customer pre-buy activity in late 2021 in advance of significant metal inflation this year.

Net sales for the metal containers segment increased $96.6 million, or 17.4 percent, in the first quarter of 2022 as compared to the same period in 2021.  This increase was primarily the result of higher average selling prices due to the pass through of higher raw material and other manufacturing costs, partially offset by lower unit volumes of approximately fourteen percent, a higher percentage of smaller cans sold and the impact of unfavorable foreign currency translation of approximately $7 million. The decrease in unit volumes was principally the result of higher customer purchases in late 2021 in advance of significant metal inflation this year and customers’ ongoing supply chain and labor challenges in the current year period.

Net sales for the custom containers segment increased $18.6 million, or 10.6 percent, in the first quarter of 2022 as compared to the same period in 2021. This increase was principally due to higher average selling prices related to the pass through of higher resin costs and a more favorable mix of products sold, partially offset by lower volumes of approximately eight percent. The decline in volumes was primarily due to strong pandemic driven demand in the first quarter of 2021.

Gross Profit.  Gross profit margin decreased 1.7 percentage points to 16.2 percent in the first quarter of 2022 as compared to the same period in 2021 for the reasons discussed below in "Income before Interest and Income Taxes."

Selling, General and Administrative Expenses.  Selling, general and administrative expenses as a percentage of consolidated net sales decreased to 7.0 percent in the first quarter of 2022 as compared to 7.9 percent in the same period in 2021. Selling, general and administrative expenses increased $2.6 million to $100.0 million for the first quarter of 2022 as compared to $97.4 million for the same period in 2021.

Income before Interest and Income Taxes.  Income before interest and income taxes for the first quarter of 2022 increased by $16.8 million as compared to the first quarter of 2021, while margins decreased to 9.9 percent from 10.2 percent over the same periods. The increase in income before interest and income taxes was primarily the result of higher income in the dispensing and specialty closures and custom containers segments, partially offset by lower income in the metal containers segment. Rationalization charges were $1.4 million and $10.3 million in the first quarters of 2022 and 2021, respectively.

Segment income of the dispensing and specialty closures segment for the first quarter of 2022 increased $21.6 million as compared to the same period in 2021, and segment income margin increased to 14.6 percent from 12.9 percent over the same periods.  The increase in segment income was primarily due to the favorable impact in the current year period from the delayed pass through of lower resin costs as compared to the unfavorable impact in the prior year period from the delayed pass through of higher resin costs, higher unit volumes including from recent acquisitions, improved operating efficiencies and lower rationalization charges, partially offset by inflation in manufacturing costs and the impact of unfavorable foreign currency translation. Rationalization charges were $5.2 million in the first quarter of 2021.

-18-

Segment income of the metal containers segment for the first quarter of 2022 decreased $7.6 million as compared to the same period in 2021, and segment income margin decreased to 5.8 percent from 8.2 percent over the same periods. The decrease in segment income was due primarily to lower unit volumes, the mix impact of more smaller cans sold and inflation in manufacturing costs, partially offset by strong manufacturing performance. The decrease in segment income margin was primarily due to to the mathematical consequence of the pass through of inflation in raw material and other manufacturing costs in the first quarter of 2022. Rationalization charges were $1.3 million and $5.0 million in the first quarters of 2022 and 2021, respectively.

Segment income of the custom containers segment for the first quarter of 2022 increased $0.2 million as compared to the same period in 2021, while segment income margin decreased to 12.8 percent from 14.0 percent over the same periods.  The increase in segment income was primarily attributable to the favorable impact in the current year period from the delayed pass through of lower resin costs as compared to the unfavorable impact in the prior year period from the delayed pass through of higher resin costs and strong operational performance, partially offset by lower volumes. The decrease in segment income margin was primarily due to the mathematical consequence of the pass through of higher raw material costs in the first quarter of 2022.

Interest and Other Debt Expense. Interest and other debt expense before loss on early extinguishment of debt for the first quarter of 2022 increased $2.9 million to $29.3 million as compared to $26.4 million in the same period in 2021. This increase was primarily due to higher weighted average outstanding borrowings during the quarter as a result of the acquisitions in the third and fourth quarters of 2021. In March 2022, we redeemed all $300.0 million aggregate principal amount of the outstanding 4¾% Notes. In conjunction with this prepayment, we recognized a loss on early extinguishment of debt of $1.5 million in the first quarter of 2022.

Provision for Income Taxes. The effective tax rates were 24.6 percent and 26.2 percent for the first quarters of 2022 and 2021, respectively. The effective tax rate for the first quarter of 2021 was unfavorably impacted by higher income in less favorable tax jurisdictions.

CAPITAL RESOURCES AND LIQUIDITY

Our principal sources of liquidity have been net cash from operating activities and borrowings under our debt instruments, including our senior secured credit facility. Our liquidity requirements arise from our obligations under the indebtedness incurred in connection with our acquisitions and the refinancing of that indebtedness, capital investment in new and existing equipment, the funding of our seasonal working capital needs and other general corporate uses.

On March 28, 2022, we redeemed all $300.0 million aggregate principal amount of the outstanding 4¾% Notes at a redemption price of 100 percent of their principal amount plus accrued and unpaid interest to the redemption date. We funded this redemption with revolving loan borrowings under the Credit Agreement and cash on hand. As a result of this redemption, we recorded a pre-tax charge for the loss on early extinguishment of debt of $1.5 million during the first quarter of 2022 for the write-off of unamortized debt issuance costs.

You should also read Note 6 to our Condensed Consolidated Financial Statements for the three months ended March 31, 2022 included elsewhere in this Quarterly Report.

For the three months ended March 31, 2022, we used net borrowings of revolving loans of $520.2 million and cash and cash equivalents of $371.9 million (including the positive effect of exchange rate changes of $1.4 million) to fund the redemption of the 4¾% Notes for $300.0 million, cash used in operations of $267.4 million, decreases in outstanding checks of $225.9 million, net capital expenditures and other investing activities of $70.0 million, dividends paid on our common stock of $18.7 million, and repurchases of our common stock of $11.5 million under our stock-based compensation plan.

For the three months ended March 31, 2021, we used proceeds from the issuance of the 1.4% Senior Secured Notes of $499.7 million, net borrowings of revolving loans of $139.2 million and cash and cash equivalents of $219.4 million to fund repayments of long-term debt of $500.0 million, cash used in operations of $172.2 million, decreases in outstanding checks of $84.2 million, net capital expenditures and other investing activities of $68.4 million, dividends paid on our common stock of $16.1 million, repurchases of our common stock of $8.3 million under our stock-based compensation plan, debt issuance costs of $4.6 million and the negative effect of exchange rate changes of $4.5 million.

-19-

At March 31, 2022, we had $508.0 million of revolving loans outstanding under the Credit Agreement.  After taking into account outstanding letters of credit, the available portion of revolving loans under the Credit Agreement at March 31, 2022 was $972.2 million.

Because we sell metal containers and closures used in fruit and vegetable pack processing, we have seasonal sales.  As is common in the industry, we must utilize working capital to build inventory and then carry accounts receivable for some customers beyond the end of the packing season.  Due to our seasonal requirements, which generally peak sometime in the summer or early fall, we may incur short-term indebtedness to finance our working capital requirements.  Our peak seasonal working capital requirements have historically averaged approximately $350 million. We fund seasonal working capital requirements through revolving loans under the Credit Agreement, other foreign bank loans and cash on hand. We may use the available portion of revolving loans under the Credit Agreement, after taking into account our seasonal needs and outstanding letters of credit, for other general corporate purposes including acquisitions, capital expenditures, dividends, stock repurchases and to refinance or repurchase other debt.

We believe that cash generated from operations and funds from borrowings available under the Credit Agreement and other foreign bank loans will be sufficient to meet our expected operating needs, planned capital expenditures, debt service, tax obligations, pension benefit plan contributions, share repurchases and common stock dividends for the foreseeable future.  We continue to evaluate acquisition opportunities in the consumer goods packaging market and may incur additional indebtedness, including indebtedness under the Credit Agreement, to finance any such acquisition.

We are in compliance with all financial and operating covenants contained in our financing agreements and believe that we will continue to be in compliance during 2022 with all of these covenants.

Guaranteed Securities

Each of the 3¼% Senior Notes, the 4⅛% Senior Notes, the 2¼% Senior Notes and the 1.4% Senior Secured Notes were issued by Silgan and are guaranteed by our U.S. subsidiaries that also guarantee our obligations under the Credit Agreement, collectively the Obligor Group.

The following summarized financial information relates to the Obligor Group as of March 31, 2022 and December 31, 2021 and for the three months ended March 31, 2022. Intercompany transactions, equity investments and other intercompany activity within the Obligor Group have been eliminated from the summarized financial information. Investments in subsidiaries of Silgan that are not part of the Obligor Group of $1.5 billion and $1.4 billion as of March 31, 2022 and December 31, 2021, respectively, are not included in noncurrent assets in the table below.

	March 31, 2022	Dec. 31, 2021
	(Dollars in millions)
Current assets	$1,412.5	$1,506.9
Noncurrent assets	4,144.9	4,159.9
Current liabilities	1,348.1	1,159.2
Noncurrent liabilities	4,050.6	4,392.4

At March 31, 2022 and December 31, 2021, the Obligor Group held current receivables due from other subsidiary companies of $36.9 million and $70.5 million, respectively; long-term notes receivable due from other subsidiary companies of $778.5 million and $782.4 million, respectively; and current payables due to other subsidiary companies of $6.6 million and $7.3 million, respectively.

	Three months ended March 31, 2022
	(Dollars in millions)
Net sales	$1,046.0
Gross profit	143.7
Net income	57.3

-20-

For the three months ended March 31, 2022, net income in the table above excludes income from equity method investments of other subsidiary companies of $27.6 million. For the three months ended March 31, 2022, the Obligor Group recorded the following transactions with other subsidiary companies: sales to such other subsidiary companies of $9.6 million; net credits from such other subsidiary companies of $7.3 million; and net interest income from such other subsidiary companies of $4.9 million. For the three months ended March 31, 2022, the Obligor Group received dividends from other subsidiary companies of $0.2 million.

Rationalization Charges

We continually evaluate cost reduction opportunities across each of our segments, including rationalizations of our existing facilities through plant closings and downsizings. We use a disciplined approach to identify opportunities that generate attractive cash returns. Under our rationalization plans, we made cash payments of $2.5 million and $2.0 million for the three months ended March 31, 2022 and 2021, respectively. Excluding the impact of our withdrawal from the Central States Pension Plan in 2019, remaining expenses and cash expenditures for our rationalization plans are expected to be $0.6 million and $2.2 million, respectively. Remaining expenses for the accretion of interest for the withdrawal liability related to the Central States Pension Plan are expected to average approximately $1.0 million per year and be recognized annually through 2040, and remaining cash expenditures for the withdrawal liability related to the Central States Pension Plan are expected to be approximately $3.1 million annually through 2040.

You should also read Note 3 to our Condensed Consolidated Financial Statements for the three months ended March 31, 2022 included elsewhere in this Quarterly Report.

-21-

Item 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Market risks relating to our operations result primarily from changes in interest rates and, with respect to our international operations, in foreign currency exchange rates.  In the normal course of business, we also have risk related to commodity price changes for items such as natural gas.  We employ established policies and procedures to manage our exposure to these risks.  Interest rate, foreign currency and commodity pricing transactions are used only to the extent considered necessary to meet our objectives.  We do not utilize derivative financial instruments for trading or other speculative purposes.

Information regarding our interest rate risk, foreign currency exchange rate risk and commodity pricing risk has been disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021.  Since such filing, other than the changes discussed in Notes 6 and 7 to our Condensed Consolidated Financial Statements for the three months ended March 31, 2022 included elsewhere in this Quarterly Report, there has not been a material change to our interest rate risk, foreign currency exchange rate risk or commodity pricing risk or to our policies and procedures to manage our exposure to these risks.

Item 4.  CONTROLS AND PROCEDURES

As required by Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, we carried out an evaluation, under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures.  Based upon that evaluation, as of the end of the period covered by this Quarterly Report, our Chief Executive Officer and Chief Financial Officer concluded that the disclosure controls and procedures were effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that our disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including the Principal Executive Officer and the Principal Financial Officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

There were no changes in our internal controls over financial reporting during the period covered by this Quarterly Report that have materially affected, or are reasonably likely to materially affect, these internal controls.

In 2021, we acquired Gateway Plastics LLC, Unicep Packaging LLC and Easytech Closures S.p.A. We are currently in the process of integrating the internal controls and procedures of these acquired entities into our internal controls over financial reporting. As provided under the Sarbanes-Oxley Act of 2002 and the applicable rules and regulations of the Securities and Exchange Commission, we will include the internal controls and procedures of these acquired entities in our annual assessment of the effectiveness of our internal control over financial reporting for our 2022 fiscal year.

-22-

Part II.  Other Information

Item 6.  Exhibits

Exhibit Number	Description
*10.1	Form of Restricted Stock Unit Agreement (Employee) under the Silgan Holdings Inc. Amended and Restated 2004 Stock Incentive Plan
*10.2	Amendment No. 3 to Silgan Holdings Inc. Senior Executive Performance Plan
22	Subsidiary Guarantors and Issuers of Guaranteed Securities (incorporated by reference to Exhibit 22 filed with our Annual Report on Form 10-K for the year ended December 31, 2021, Commission File No. 000-22117).
*31.1	Certification by the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act.
*31.2	Certification by the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act.
*32.1	Certification by the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act.
*32.2	Certification by the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act.
101.INS	XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH	Inline XBRL Taxonomy Extension Schema Document.
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104	Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).

___________________ 

*Filed herewith.

-23-

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Quarterly Report to be signed on its behalf by the undersigned thereunto duly authorized.

 

	SILGAN HOLDINGS INC.
Dated: May 4, 2022	/s/ Robert B. Lewis
	Robert B. Lewis
	Executive Vice President and
	Chief Financial Officer
	(Principal Financial and
	Accounting Officer)

-24-

EX-10.1

Exhibit 10.1

Silgan Holdings Inc.

Amended and Restated

2004 Stock Incentive Plan

FORM OF

RESTRICTED STOCK UNIT AGREEMENT

__________________________

(Employee)

Date of Grant: __________________

Restricted Stock Units: ______

RESTRICTED STOCK UNIT AGREEMENT made in Stamford, Connecticut, between Silgan Holdings Inc. and ____________________.

1. Grant of Award. The Company has granted you ________ Restricted Stock Units, subject to the provisions of this Agreement. The Company will hold the Restricted Stock Units in a bookkeeping account on your behalf until they are paid or are forfeited or cancelled.

2. Payment Amount. Each Restricted Stock Unit represents the equivalent of one (1) Share of common stock of the Company.

[3. Performance Measures. These Restricted Stock Units are intended to be “performance-based compensation”, as that term is used in Section 162(m) of the Internal Revenue Code (the “Code”), and have been granted to you [as a result of] [subject to] the attainment by the [Company] [Subsidiary of the Company] [of the minimum level] of the Performance Criteria [previously set] [fixed and established for this grant] by the Compensation Committee (the “Committee”), [at a meeting duly held on __________] [by resolution dated __________] for the Performance Cycle beginning on and ending on ___________________, as the same shall be certified by the Committee following the end of such period. [This Agreement and the grant of these Restricted Stock Units hereunder shall be cancelled and be null and void unless the Company attains the minimum level of such Performance Criteria for such Performance Cycle as so fixed and established for this grant by the Committee.]]*

4. Vesting. [The restrictions on your Restricted Stock Units will lapse incrementally and your Restricted Stock Units will vest as follows: ____________________.**

Your vested rights will be calculated on the anniversary of the Date of Grant. No partial credit will be given for partial years of employment.] [The restrictions on your Restricted Stock Units will lapse and all of these Restricted Stock Units will vest at once on ___________.]** If your employment with the Company terminates before your Restricted Stock Units are fully vested, except in the event of your death or Disability or a Change in Control, unvested Restricted Stock Units will immediately be forfeited, and your rights with respect to these Restricted Stock Units will end. [Upon your death or Disability, all unvested Restricted Stock Units[, whether or not any applicable Performance Criteria has been attained,]*shall immediately vest in full, and all such

_________________________

*Include as applicable if grant is performance based

** Include applicable vesting provisions

1

Restricted Stock Units shall be immediately settled in Shares.]*** [Upon your death or Disability, a pro rata portion of all unvested Restricted Stock Units (based on the number of years, including partial years, from the Date of Grant until the date of your death or Disability over the total number of years, including partial years, from the Date of Grant until the vesting date)[, whether or not any applicable Performance Criteria has been attained,]* shall immediately vest in full, and such pro rata portion of such Restricted Stock Units shall be immediately settled in Shares.]**** If you are deceased, the Company will issue such Shares to your estate only after the Company has determined that the payee is the duly appointed executor or administrator of your estate.

5.     Form of Payment. Vested Restricted Stock Units will be settled in Shares.

[6. Dividend Equivalents. Each Restricted Stock Unit carries with it a right to dividend equivalents, entitling you to be credited with an amount equal to all cash dividends paid on one Share of common stock of the Company while the Restricted Stock Unit is outstanding and until the Restricted Stock Unit vests, subject to this Section 6. You will be credited with such amounts of dividend equivalents in respect of each Restricted Stock Unit, provided that such Restricted Stock Unit was outstanding on, and had not vested prior to, the applicable record date for such cash dividend. All such amounts of dividend equivalents credited to you in respect of each Restricted Stock Unit will be paid to you upon the vesting of such Restricted Stock Unit. In the event that any Restricted Stock Unit does not vest and is forfeited, all such amounts of dividend equivalents credited to you in respect of such Restricted Stock Unit shall be likewise forfeited by you. Such amounts of dividend equivalents credited to you in respect of unvested Restricted Stock Units represent an unfunded and unsecured obligation of the Company, subject to the terms of this Agreement.]*****

[7. Deferral of Delivery.

(a) If you would like to defer delivery of all Shares to a date subsequent to the date of vesting of the Restricted Stock Units, you may make a written request to the Company for deferral, including a suggested delivery date no earlier than 5 years and no later than 10 years following the Date of Grant. This request must be made within 30 days after the Date of Grant. The Company may, in its sole discretion, determine whether to permit deferral of delivery in the manner requested. If the Company does not accept your suggested delivery date, then you will be notified of this decision in writing and your Shares will be delivered to you as your Restricted Stock Units vest. If the Company accepts your proposal, subject to Section 8 hereof, you will be bound by the deferred delivery date, unless the deferral period is extended as provided in (b).

(b) If your deferral period expires prior to the termination of your employment with the Company and you would like to extend your deferral period, you may, at least 13 months prior to the date on which your initial deferral period is scheduled to expire, make a written request to the Company for an extension of the deferral period, including a revised delivery date no later than 30 years following the Date of Grant. The Company may, in its sole discretion, determine whether to permit deferral of delivery in the manner requested. If the Company does not accept your proposed revised delivery date, you will be notified of this

_________________________

* Include as applicable if grant is performance-based.

***Include for all grants of Restricted Stock Units except grants that vest all at once on one date.

****Include for grants of Restricted Stock Units that vest all at once on one date.

*****Include if dividend equivalents are applicable.

2

decision in writing and the Shares will be delivered to you at the end of the initial deferral period. If the Company accepts your proposal, subject to Section 8 hereof, you will be bound by the revised delivery date, which may not be revoked.

(c) Under no circumstances may a deferral period be extended more than once.

(d) Notwithstanding the foregoing, the Committee may, in its discretion, distribute Shares from your deferral account prior to the expiration of your deferral period in the event you have an unforeseeable emergency. An “unforeseeable emergency” for this purpose is an unanticipated emergency caused by an event beyond your control that would result in severe financial hardship if the distribution were not permitted. Emergency distributions will be limited to the amount necessary to satisfy the financial hardship.

(e) Except as otherwise determined by the Committee, in its sole discretion, you will be paid a Dividend Equivalent in an amount equal to any cash dividends paid by the Company upon one Share of common stock for each vested Restricted Stock Unit credited to your deferral account. Dividend Equivalents will be paid to you in cash as soon as practicable after dividends are distributed to stockholders.

(f) All deferral elections and distributions from your deferral account will be subject to applicable law, including changes in law affecting outstanding deferral elections. The Committee has the authority to modify outstanding deferral elections to the extent necessary to comply with changes in applicable law.]******

[8. Termination of Employment. If your employment with the Company terminates for any reason (including in the event of your Retirement, death or Disability), Shares on any deferred vested Restricted Stock Units will be distributed to you as soon as practicable following such termination. If you are deceased, the Company will make a distribution to your estate only after the Company has determined that the payee is the duly appointed executor or administrator of your estate.]******

9. Change in Control. In the event of a Change in Control, the vesting of any unvested Restricted Stock Units [and the distribution of any Shares on Restricted Stock Units credited to your deferral account]****** will be in accordance with the terms of the Plan.

10. Withholdings. The Company will have the right, prior to the issuance or delivery of any Shares on your Restricted Stock Units, to withhold or demand from you the amount necessary to satisfy the applicable tax requirements. Your withholding obligations will be satisfied through the withholding by the Company of Shares that otherwise would be issued to you on your Restricted Stock Units, unless you have notified the Company in writing at least 3 days prior to any date you are to receive Shares on your Restricted Stock Units that you will otherwise satisfy your applicable withholding tax obligations in cash. The Shares will be valued at their Fair Market Value as of the date when the Shares would otherwise be issued to you. Only full Shares may be used to satisfy your withholding tax obligations. If the legally required minimum tax withholding would result in a fractional Share being withheld, the withholding amount will be rounded up so that a full Share may be withheld instead. [For any dividend

_________________________

****** Include if deferral is applicable.

3

equivalents paid pursuant to Section 6 hereof, the Company will also have the right to withhold amounts necessary to satisfy applicable withholding tax requirements in respect thereof.]*****

11. Transfer of Award. You may not transfer any interest in your Restricted Stock Units, except by will or the laws of descent and distribution. Any other attempt to dispose of your interest in Restricted Stock Units will be null and void.

12. Adjustments. In the event of any subdivision of the common stock of the Company, a declaration of a dividend payable in Shares, or a combination or consolidation of the outstanding common stock (by reclassification or otherwise), the Committee will make appropriate adjustments to the number and kind of Shares covered by the Restricted Stock Units and other relevant provisions, to the extent necessary to prevent dilution or enlargement of the benefits or potential benefits intended to be provided by the Restricted Stock Units. Any such determinations and adjustments made by the Committee will be binding on all persons.

13. Restrictions on Distribution of Shares. The Company will not be required to deliver any Shares until all applicable federal and state laws and regulations and all applicable national securities exchange or national securities association rules have been complied with and all legal matters in connection with the issuance and delivery of the Shares have been approved by counsel of the Company.

14.    Disposition of Securities. By accepting the Award and signing this Agreement, you acknowledge that you have read and understand the Company’s policy on, and are aware of and understand your obligations under federal securities laws with respect to, trading in the Company’s securities. The Company will have the right to recover, or receive reimbursement for, any compensation or profit you realize on the disposition of Shares received for Restricted Stock Units to the extent that the Company has a right of recovery or reimbursement under applicable securities laws. If you are an “affiliate” of the Company, you may dispose of any Shares paid on your Restricted Stock Units only pursuant to an effective registration statement under the Securities Act of 1933 or an exemption or exclusion from the registration requirement.

15. Plan Terms Govern. The grant of Restricted Stock Units, the settlement of Restricted Stock Units in Shares, and the disposition of such Shares are subject to the provisions of the Plan and any rules that the Committee may prescribe. The Plan document, as may be amended from time to time, is incorporated into this Agreement. Capitalized terms used in this Agreement have the meaning set forth in the Plan, unless otherwise stated in this Agreement. In the event of any conflict between the terms of the Plan and the terms of this Agreement, the Plan will control. By accepting the Award, you acknowledge receipt of the Plan, as in effect on the date of this Agreement.

16. Personal Data. To comply with applicable law and to administer the Plan and this Agreement properly, the Company and its agents may hold and process your personal data, including your home address, Social Security number, employment status, hire date and termination date. By accepting the Award, you expressly consent to the use of this data by the Company and its agents and to the transfer of this data outside the country in which you perform services or reside.

_________________________

*****Include if dividend equivalents are applicable.

4

17. Limitations. Nothing in this Agreement or the Plan gives you any right to continue in the employ of the Company or any of its Affiliates or to interfere in any way with the right of the Company or any of its Affiliates to terminate your employment at any time. Distribution of Shares on your Restricted Stock Units is not secured by a trust, insurance contract or other funding medium, and you do not have any interest in any fund or specific asset of the Company by reason of this Award or the account established on your behalf. You have no voting rights or other rights as a stockholder of the Company pursuant to the Restricted Stock Units until Shares are actually distributed to you.

18. Incorporation of Other Agreements. This Agreement and the Plan constitute the entire understanding between you and the Company regarding the Restricted Stock Units. This Agreement supersedes any prior agreements, commitments or negotiations concerning the Restricted Stock Units.

19. Severability. The invalidity or unenforceability of any provision of this Agreement will not affect the validity or enforceability of the other provisions of the Agreement, which will remain in full force and effect. Moreover, if any provision is found to be excessively broad in duration, scope or covered activity, the provision will be construed so as to be enforceable to the maximum extent compatible with applicable law.

5

By accepting this Award and signing below, you confirm the following:

(i) you have carefully read, fully understand and agree to all of the terms and conditions described in this Agreement and the Plan; and

(ii) you understand and agree that this Agreement and the Plan constitute the entire understanding between you and the Company regarding the Award, and that any prior agreements, commitments or negotiations concerning the Restricted Stock Units are replaced and superseded.

SILGAN HOLDINGS INC.

By: _______________________

Name:

Title:

EMPLOYEE

________________________________

(Signature)

________________________________

(Print Name)

________________________________

(Address)

________________________________

(City, State, Zip Code)

________________________________

(Country)

6

EX-10.2

Exhibit 10.2

AMENDMENT NO. 3 TO

SILGAN HOLDINGS INC. SENIOR EXECUTIVE PERFORMANCE PLAN

WHEREAS, the Silgan Holdings Inc. Senior Executive Performance Plan (the “Plan”) was adopted by both the Board of Directors of Silgan Holding Inc. (the “Company”) and the Compensation Committee of the Board of Directors of the Company (the “Compensation Committee”) on February 27, 2003, and was approved by the Company’s stockholders on June 5, 2003;

WHEREAS, on March 1, 2006, the Compensation Committee approved an Amendment to the Plan (“Amendment No. 1”), and the stockholders of the Company approved Amendment No. 1 at the Company’s annual meeting of stockholders on June 7, 2006;

WHEREAS, on March 28, 2016, the Compensation Committee approved Amendment No. 2 to the Silgan Holdings Inc. Senior Executive Performance Plan (“Amendment No. 2”), which Amendment No. 2 did not require approval of the stockholders of the Company;

WHEREAS, the Compensation Committee has determined that it is in the best interest of the Company to further amend the Plan, as amended by Amendment No. 1 and Amendment No. 2 (the “Amended Plan”), as provided below, and in accordance with the Amended Plan the Compensation Committee has full authority to amend the Amended Plan; and

WHEREAS, this Amendment No. 3 to the Amended Plan (this “Amendment No. 3”) does not require approval of the stockholders of the Company.

NOW, THEREFORE, the Company does hereby amend the Amended Plan as follows, effective as of January 1, 2022:

1. Section 2 of the Plan is hereby amended such that the definitions of “EXECUTIVE” and “MAXIMUM AWARD” are deleted and replaced in their entirety with the following:

“EXECUTIVE” shall mean Adam J. Greenlee, the current Chief Executive Officer of the Company.

“MAXIMUM AWARD” shall mean, with respect to Adam J. Greenlee, for any Performance Period, a percentage of his annual salary as determined by the Committee, with such percentage being no less than 100% and no more than 200%.

2. All the terms and provisions of the Amended Plan shall continue in full force and effect, as modified by this Amendment No. 3.

IN WITNESS WHEREOF, the undersigned officer of the Company has duly executed this Amendment No. 3 as of February 23, 2022.

SILGAN HOLDINGS INC.

By: /s/ Frank W. Hogan, III

Name: Frank W. Hogan, III

Title: Senior Vice President, General Counsel & Secretary

1

EX-31.1

Exhibit 31.1

CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT

I, Adam J. Greenlee, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the period ended March 31, 2022 of Silgan Holdings Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.   Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  May 4, 2022	/s/ Adam J. Greenlee
	Adam J. Greenlee
	President and
	Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION BY THE CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT

I, Robert B. Lewis, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the period ended March 31, 2022 of Silgan Holdings Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.   Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.   Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.   Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  May 4, 2022	/s/ Robert B. Lewis
	Robert B. Lewis
	Executive Vice President and
	Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT

In connection with the Quarterly Report of Silgan Holdings Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Quarterly Report”), I, Adam J. Greenlee, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Quarterly Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Adam J. Greenlee

Adam J. Greenlee

President and

Chief Executive Officer

May 4, 2022

A signed original of this written statement required by Section 906 has been provided to Silgan Holdings Inc. and will be retained by Silgan Holdings Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

CERTIFICATION BY THE CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT

In connection with the Quarterly Report of Silgan Holdings Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Quarterly Report”), I, Robert B. Lewis, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Quarterly Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Robert B. Lewis

Robert B. Lewis

Executive Vice President and

Chief Financial Officer

May 4, 2022

A signed original of this written statement required by Section 906 has been provided to Silgan Holdings Inc. and will be retained by Silgan Holdings Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Cover - shares	3 Months Ended
	Mar. 31, 2022	Apr. 30, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2022
Document Transition Report	false
Entity File Number	000-22117
Entity Registrant Name	SILGAN HOLDINGS INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	06-1269834
Entity Address, Address Line One	4 Landmark Square
Entity Address, City or Town	Stamford,
Entity Address, State or Province	CT
Entity Address, Postal Zip Code	06901
City Area Code	203
Local Phone Number	975-7110
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	SLGN
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		110,800,407
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Entity Central Index Key	0000849869
Current Fiscal Year End Date	--12-31

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021
Current assets:
Cash and cash equivalents	$ 259,564	$ 631,439	$ 190,131
Trade accounts receivable, net	852,876	711,332	738,088
Inventories	1,018,685	798,837	788,637
Prepaid expenses and other current assets	150,646	154,241	102,382
Total current assets	2,281,771	2,295,849	1,819,238
Property, plant and equipment, net	1,979,681	1,993,877	1,811,593
Goodwill	2,024,340	2,038,408	1,701,040
Other intangible assets, net	817,450	830,772	613,220
Other assets, net	607,168	611,940	496,381
Assets, total	7,710,410	7,770,846	6,441,472
Current liabilities:
Revolving loans and current portion of long-term debt	539,134	20,251	195,122
Trade accounts payable	850,532	1,133,318	629,494
Accrued payroll and related costs	109,096	109,279	105,745
Accrued liabilities	218,194	245,674	224,747
Total current liabilities	1,716,956	1,508,522	1,155,108
Long-term debt	3,445,633	3,772,926	3,163,292
Deferred income taxes	433,843	435,252	357,587
Other liabilities	475,739	491,450	489,129
Stockholders’ equity:
Common stock	1,751	1,751	1,751
Paid-in capital	328,201	325,448	309,635
Retained earnings	2,758,697	2,691,745	2,452,996
Accumulated other comprehensive loss	(244,642)	(259,828)	(291,806)
Treasury stock	(1,205,768)	(1,196,420)	(1,196,220)
Total stockholders’ equity	1,638,239	1,562,696	1,276,356
Liabilities and equity, total	$ 7,710,410	$ 7,770,846	$ 6,441,472

XML

Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Net sales	$ 1,441,886	$ 1,238,110
Cost of goods sold	1,208,433	1,016,644
Gross profit	233,453	221,466
Selling, general and administrative expenses	100,011	97,379
Rationalization charges	1,379	10,357
Other pension and postretirement income	(11,329)	(12,819)
Income before interest and income taxes	143,392	126,549
Interest and other debt expense before loss on early extinguishment of debt	29,349	26,423
Loss on early extinguishment of debt	1,481	883
Interest and other debt expense	30,830	27,306
Income before income taxes	112,562	99,243
Provision for income taxes	27,687	25,962
Net income	$ 84,875	$ 73,281
Earnings per share
Basic net income per share (usd per share)	$ 0.77	$ 0.66
Diluted net income per share (usd per share)	$ 0.76	$ 0.66
Weighted average number of shares
Basic (in shares)	110,600	110,206
Effect of dilutive securities (in shares)	793	824
Diluted (in shares)	111,393	111,030

XML

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 84,875	$ 73,281
Other comprehensive income (loss), net of tax:
Changes in net prior service credit and actuarial losses	499	1,878
Change in fair value of derivatives	2,337	641
Foreign currency translation	12,350	(33,372)
Other comprehensive income (loss)	15,186	(30,853)
Comprehensive income	$ 100,061	$ 42,428

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows provided by (used in) operating activities:
Net income	$ 84,875	$ 73,281
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	69,067	60,872
Rationalization charges	1,379	10,357
Stock compensation expense	4,879	5,010
Loss on early extinguishment of debt	1,481	883
Other changes that provided (used) cash, net of effects from acquisitions:
Trade accounts receivable, net	(141,113)	(103,549)
Inventories	(222,137)	(118,132)
Trade accounts payable	(29,881)	(59,825)
Accrued liabilities	(23,291)	(32,062)
Other, net	(12,660)	(8,983)
Net cash used in operating activities	(267,401)	(172,148)
Cash flows provided by (used in) investing activities:
Purchase of businesses, net of cash acquired	(1,333)	0
Capital expenditures	(68,491)	(68,764)
Other, net	(203)	402
Net cash used in investing activities	(70,027)	(68,362)
Cash flows provided by (used in) financing activities:
Borrowings under revolving loans	544,624	170,457
Repayments under revolving loans	(24,408)	(31,310)
Proceeds from issuance of long-term debt	0	499,725
Repayments of long-term debt	(300,000)	(500,000)
Changes in outstanding checks - principally vendors	(225,863)	(84,216)
Dividends paid on common stock	(18,722)	(16,055)
Debt issuance costs	0	(4,633)
Repurchase of common stock	(11,474)	(8,275)
Net cash (used in) provided by financing activities	(35,843)	25,693
Effect of exchange rate changes on cash and cash equivalents	1,396	(4,533)
Cash and cash equivalents:
Net decrease	(371,875)	(219,350)
Balance at beginning of year	631,439	409,481
Balance at end of period	259,564	190,131
Interest paid, net	33,116	31,655
Income taxes paid, net	$ 6,718	$ 15,297

XML

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Treasury Stock
Beginning balance at Dec. 31, 2020		$ 1,751	$ 306,363	$ 2,395,395	$ (260,953)	$ (1,189,683)
Beginning balance (in shares) at Dec. 31, 2020		110,057
Increase (Decrease) in Stockholders' Equity
Net issuance of treasury stock for vested restricted stock units (in shares)		329
Stock compensation expense			5,010
Net issuance of treasury stock for vested restricted stock units			(1,738)			(6,537)
Net income	$ 73,281			73,281
Dividends declared on common stock				(15,680)
Other comprehensive income (loss)					(30,853)
Ending balance at Mar. 31, 2021	$ 1,276,356	$ 1,751	309,635	2,452,996	(291,806)	(1,196,220)
Ending balance (in shares) at Mar. 31, 2021		110,386
Increase (Decrease) in Stockholders' Equity
Dividends declared on common stock per share (usd per share)	$ 0.14
Beginning balance at Dec. 31, 2021	$ 1,562,696	$ 1,751	325,448	2,691,745	(259,828)	(1,196,420)
Beginning balance (in shares) at Dec. 31, 2021		110,410
Increase (Decrease) in Stockholders' Equity
Net issuance of treasury stock for vested restricted stock units (in shares)		390
Stock compensation expense			4,879
Net issuance of treasury stock for vested restricted stock units			(2,126)			(9,348)
Net income	84,875			84,875
Dividends declared on common stock				(17,923)
Other comprehensive income (loss)					15,186
Ending balance at Mar. 31, 2022	$ 1,638,239	$ 1,751	$ 328,201	$ 2,758,697	$ (244,642)	$ (1,205,768)
Ending balance (in shares) at Mar. 31, 2022		110,800
Increase (Decrease) in Stockholders' Equity
Dividends declared on common stock per share (usd per share)	$ 0.16

XML

Significant Accounting Policies

3 Months Ended

Mar. 31, 2022

Accounting Policies [Abstract]

Significant Accounting Policies

Significant Accounting Policies

Basis of Presentation. The accompanying unaudited condensed consolidated financial statements of Silgan Holdings Inc., or Silgan, have been prepared in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the accompanying financial statements include all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation. The results of operations for any interim period are not necessarily indicative of the results of operations for the full year.

The Condensed Consolidated Balance Sheet at December 31, 2021 has been derived from our audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.

You should read the accompanying condensed consolidated financial statements in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2021.

XML

Revenue

3 Months Ended

Mar. 31, 2022

Revenue Recognition [Abstract]

Revenue

Revenue

The following tables present our revenues disaggregated by reportable segment and geography as they best depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. Revenues by segment for the three months ended March 31 were as follows:

	2022		2021
	(Dollars in thousands)
Dispensing and Specialty Closures	$	597,927	$	509,352
Metal Containers	650,726		554,081
Custom Containers	193,233		174,677
	$	1,441,886	$	1,238,110

Revenues by geography for the three months ended March 31 were as follows:

	2022		2021
	(Dollars in thousands)
North America	$	1,086,224	$	898,402
Europe and other	355,662		339,708
	$	1,441,886	$	1,238,110

Our contract assets primarily consist of unbilled accounts receivable related to over time revenue recognition and were $99.1 million, $86.4 million, and $78.2 million as of March 31, 2022 and 2021 and December 31, 2021, respectively. Unbilled receivables are included in trade accounts receivable, net on our Condensed Consolidated Balance Sheets.

XML

Rationalization Charges

3 Months Ended

Mar. 31, 2022

Restructuring and Related Activities [Abstract]

Rationalization Charges

Rationalization Charges

We continually evaluate cost reduction opportunities across each of our segments, including rationalizations of our existing facilities through plant closings and downsizings. We use a disciplined approach to identify opportunities that generate attractive cash returns. Rationalization charges by segment for the three months ended March 31 were as follows:

	2022		2021
	(Dollars in thousands)
Dispensing and Specialty Closures	$	—	$	5,231
Metal Containers	1,274		5,021
Custom Containers	105		105
	$	1,379	$	10,357

Activity in reserves for our rationalization plans were as follows:

	Employee Severance and Benefits		Plant Exit Costs		Non-Cash Asset Write-Down		Total
	(Dollars in thousands)
Balance at December 31, 2021	$	41,090	$	157	$	—	$	41,247
Charged to expense	621		733		25		1,379
Utilized and currency translation	(1,839)		(702)		(25)		(2,566)
Balance at March 31, 2022	$	39,872	$	188	$	—	$	40,060

Non-cash asset write-downs were the result of comparing the carrying value of certain production related assets to their fair value using estimated future discounted cash flows, a Level 3 fair value measurement (see Note 7 for information regarding a Level 3 fair value measurement).

Rationalization reserves as of March 31, 2022 were recorded in our Condensed Consolidated Balance Sheet as accrued liabilities of $4.8 million and other liabilities of $35.3 million. Excluding the impact of our withdrawal from the Central States, Southeast and Southwest Areas Pension Plan, or the Central States Pension Plan, in 2019, remaining expenses and cash expenditures for our rationalization plans are expected to be $0.6 million and $2.2 million, respectively. Remaining expenses for the accretion of interest for the withdrawal liability related to the Central States Pension Plan are expected to average approximately $1.0 million per year and be recognized annually through 2040, and remaining cash expenditures for the withdrawal liability related to the Central States Pension Plan are expected to be approximately $3.1 million annually through 2040.

XML

Accumulated Other Comprehensive Loss

3 Months Ended

Mar. 31, 2022

Equity [Abstract]

Accumulated Other Comprehensive Loss

Accumulated Other Comprehensive Loss

Accumulated other comprehensive loss is reported in our Condensed Consolidated Statements of Stockholders’ Equity.  Amounts included in accumulated other comprehensive loss, net of tax, were as follows:

 

	Unrecognized Net Defined Benefit Plan Costs		Change in Fair Value of Derivatives		Foreign Currency Translation		Total
	(Dollars in thousands)
Balance at December 31, 2021	$	(119,474)	$	(2,327)	$	(138,027)	$	(259,828)
Other comprehensive income before reclassifications	—		2,018		12,350		14,368
Amounts reclassified from accumulated other     comprehensive loss	499		319		—		818
Other comprehensive income	499		2,337		12,350		15,186
Balance at March 31, 2022	$	(118,975)	$	10	$	(125,677)	$	(244,642)

The amounts reclassified to earnings from the unrecognized net defined benefit plan costs component of accumulated other comprehensive loss for the three months ended March 31, 2022 were net (losses) of $(0.7) million, excluding an income tax benefit of $0.2 million. These net (losses) consisted of amortization of net actuarial (losses) of $(1.1) million and amortization of net prior service credit of $0.4 million. Amortization of net actuarial losses and net prior service credit was recorded in other pension and postretirement income in our Condensed Consolidated Statements of Income. See Note 9 for further information.

The amounts reclassified to earnings from the change in fair value of derivatives component of accumulated other comprehensive loss for the three months ended March 31, 2022 were not significant.

Other comprehensive loss before reclassifications related to foreign currency translation for the three months ended March 31, 2022 consisted of (i) foreign currency gains related to translation of quarter end financial statements of foreign subsidiaries utilizing a functional currency other than the U.S. dollar of $3.0 million, (ii) foreign currency gains related to intra-entity foreign currency transactions that are of a long-term investment nature of $0.8 million, and (iii) foreign currency gains related to our net investment hedges of $11.3 million, excluding an income tax (provision) of $(2.7) million. See Note 7 for further discussion.

XML

Inventories

3 Months Ended

Mar. 31, 2022

Inventory Disclosure [Abstract]

Inventories

Inventories

Inventories consisted of the following: 

	March 31, 2022		March 31, 2021		Dec. 31, 2021
	(Dollars in thousands)
Raw materials	$	295,713	$	263,580	$	394,102
Work-in-process	263,878		167,137		157,406
Finished goods	607,087		452,553		394,378
Other	14,787		14,955		15,731
	1,181,465		898,225		961,617
Adjustment to value inventory at cost on the LIFO method	(162,780)		(109,588)		(162,780)
	$	1,018,685	$	788,637	$	798,837

XML

Long-Term Debt

3 Months Ended

Mar. 31, 2022

Debt Disclosure [Abstract]

Long-Term Debt

Long-Term Debt

Long-term debt consisted of the following: 

	March 31, 2022		March 31, 2021		Dec. 31, 2021
	(Dollars in thousands)
Bank debt
Bank revolving loans	$	508,000	$	137,000	$	—
U.S. term loans	1,000,000		400,000		1,000,000
Other foreign bank revolving and term loans	50,014		60,030		38,862
Total bank debt	1,558,014		597,030		1,038,862
4¾% Senior Notes	—		300,000		300,000
3¼% Senior Notes	723,190		763,945		739,180
4⅛% Senior Notes	600,000		600,000		600,000
2¼% Senior Notes	556,300		587,650		568,600
1.4% Senior Secured Notes	500,000		500,000		500,000
Finance leases	67,714		33,936		68,730
Total debt - principal	4,005,218		3,382,561		3,815,372
Less unamortized debt issuance costs and debt discount	20,451		24,147		22,195
Total debt	3,984,767		3,358,414		3,793,177
Less current portion	539,134		195,122		20,251
	$	3,445,633	$	3,163,292	$	3,772,926

At March 31, 2022, the current portion of long-term debt consisted of $508.0 million of bank revolving loans under our amended and restated senior secured credit facility, as amended, or the Credit Agreement, $28.4 million of other foreign bank revolving and term loans and $2.7 million of finance leases.

On March 28, 2022, we redeemed all $300.0 million aggregate principal amount of our outstanding 4¾% Senior Notes due 2025, or the 4¾% Notes, at a redemption price of 100 percent of their principal amount plus accrued and unpaid interest to the redemption date. We funded this redemption with revolving loan borrowings under the Credit Agreement and cash on hand. As a result of this redemption, we recorded a pre-tax charge for the loss on early extinguishment of debt of $1.5 million during the first quarter of 2022 for the write-off of unamortized debt issuance costs.

XML

Financial Instruments

3 Months Ended

Mar. 31, 2022

Investments, All Other Investments [Abstract]

Financial Instruments

Financial Instruments

The financial instruments recorded in our Condensed Consolidated Balance Sheets include cash and cash equivalents, trade accounts receivable, trade accounts payable, debt obligations and swap agreements. Due to their short-term maturity, the carrying amounts of trade accounts receivable and trade accounts payable approximate their fair market values. The following table summarizes the carrying amounts and estimated fair values of our other financial instruments at March 31, 2022:

	Carrying Amount		Fair Value
	(Dollars in thousands)
Assets:
Cash and cash equivalents	$	259,564	$	259,564
Liabilities:
Bank debt	$	1,558,014	$	1,558,014
3¼% Senior Notes	723,190		721,671
4⅛% Senior Notes	599,229		575,280
2¼% Senior Notes	556,300		507,624
1.4% Senior Secured Notes	499,784		456,550

Fair Value Measurements

GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). GAAP classifies the inputs used to measure fair value into a hierarchy consisting of three levels. Level 1 inputs represent unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 inputs represent unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability. Level 3 inputs represent unobservable inputs for the asset or liability. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

Financial Instruments Measured at Fair Value

The financial assets and liabilities that were measured on a recurring basis at March 31, 2022 consisted of our cash and cash equivalents and derivative instruments. We measured the fair value of cash and cash equivalents using Level 1 inputs. We measured the fair value of our derivative instruments using the income approach. The fair value of our derivative instruments reflects the estimated amounts that we would pay or receive based on the present value of the expected cash flows derived from market interest rates and prices. As such, these derivative instruments were classified within Level 2.

Financial Instruments Not Measured at Fair Value

Our bank debt, 3¼% Senior Notes, 4⅛% Senior Notes, 2¼% Senior Notes and 1.4% Senior Secured Notes were recorded at historical amounts in our Condensed Consolidated Balance Sheets, as we have not elected to measure them at fair value. We measured the fair value of our variable rate bank debt using the market approach based on Level 2 inputs. Fair values of the 3¼% Senior Notes, 4⅛% Senior Notes, 2¼% Senior Notes and 1.4% Senior Secured Notes were estimated based on quoted market prices, a Level 1 input.

Derivative Instruments and Hedging Activities

Our derivative financial instruments were recorded in the Condensed Consolidated Balance Sheets at their fair values. Changes in fair values of derivatives are recorded in each period in earnings or comprehensive income, depending on whether a derivative is designated as part of a hedge transaction and, if it is, the type of hedge transaction.

We utilize certain derivative financial instruments to manage a portion of our interest rate and natural gas cost exposures. We generally limit our use of derivative financial instruments to interest rate and natural gas swap agreements. We do not engage in trading or other speculative uses of these financial instruments. For a financial instrument to qualify as a hedge, we must be exposed to interest rate or price risk, and the financial instrument must reduce the exposure and be designated as a hedge. Financial instruments qualifying for hedge accounting must maintain a high correlation between the hedging instrument and the item being hedged, both at inception and throughout the hedged period.

We also utilize certain internal hedging strategies to minimize our foreign currency exchange rate risk. Net investment hedges that qualify for hedge accounting result in the recognition of foreign currency gains or losses, net of tax, in accumulated other comprehensive loss. 

Interest Rate Swap Agreements

We have entered into two U.S. dollar interest rate swap agreements, each for $50.0 million notional principal amount, to manage a portion of our exposure to interest rate fluctuations. These agreements have a fixed rate of 2.878 percent and mature on March 24, 2023. The difference between amounts to be paid or received on our interest rate swap agreements is recorded in interest and other debt expense in our Condensed Consolidated Statements of Income and was not significant for the three months ended March 31, 2022. These agreements are with a financial institution which is expected to fully perform under the terms thereof. The total fair value of our interest rate swap agreements in effect at March 31, 2022 was not significant.

Natural Gas Swap Agreements

We have entered into natural gas swap agreements to manage a portion of our exposure to fluctuations in natural gas prices. The difference between amounts to be paid or received on our natural gas swap agreements is recorded in cost of goods sold in our Condensed Consolidated Statements of Income and was not significant for the three months ended March 31, 2022. These agreements are with a financial institution which is expected to fully perform under the terms thereof. The total fair value of our natural gas swap agreements in effect at March 31, 2022 was not significant.

Foreign Currency Exchange Rate Risk

In an effort to minimize our foreign currency exchange rate risk, we have financed acquisitions of foreign operations primarily with borrowings denominated in Euros. In addition, where available, we have borrowed funds in local currency or implemented certain internal hedging strategies to minimize our foreign currency exchange rate risk related to foreign operations, including net investment hedges related to the 3¼% Senior Notes which are Euro denominated. Foreign currency gains related to our net investment hedges included in accumulated other comprehensive loss for the three months ended March 31, 2022 were $11.3 million.

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2022

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

A competition authority in Germany commenced an antitrust investigation in 2015 involving the industry association for metal packaging in Germany and its members, including our metal closures and metal container subsidiaries in Germany. At the end of April 2018, the European Commission commenced an antitrust investigation involving the metal packaging industry in Europe including our metal closures and metal container subsidiaries, which should effectively close out the investigation in Germany. Given the current stage of the investigation, we cannot reasonably assess what actions may result from these investigations or estimate what costs we may incur as a result thereof.

We are a party to other legal proceedings, contract disputes and claims arising in the ordinary course of our business. We are not a party to, and none of our properties are subject to, any pending legal proceedings which could have a material adverse effect on our business or financial condition.

XML

Retirement Benefits

3 Months Ended

Mar. 31, 2022

Retirement Benefits [Abstract]

Retirement Benefits

Retirement Benefits

The components of the net periodic pension benefit credit for the three months ended March 31 were as follows:

	2022		2021
	(Dollars in thousands)
Service cost	$	3,300	$	3,788
Interest cost	5,159		4,354
Expected return on plan assets	(17,314)		(19,848)
Amortization of prior service cost	55		58
Amortization of actuarial losses	1,155		3,026
Net periodic benefit credit	$	(7,645)	$	(8,622)

The components of the net periodic other postretirement benefit credit for the three months ended March 31 were as follows:

	2022		2021
	(Dollars in thousands)
Service cost	$	25	$	28
Interest cost	109		95
Amortization of prior service credit	(416)		(456)
Amortization of actuarial gains	(77)		(48)
Net periodic benefit credit	$	(359)	$	(381)

XML

Income Taxes	3 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income TaxesSilgan and its subsidiaries file U.S. Federal income tax returns, as well as income tax returns in various states and foreign jurisdictions. The Internal Revenue Service, or IRS, has completed its review of the 2020 tax year with no change to our filed federal income tax return. We have been accepted into the Compliance Assurance Program for the 2021 and 2022 tax years which provides for the review by the IRS of tax matters relating to our tax return prior to filing.

XML

Treasury Stock

3 Months Ended

Mar. 31, 2022

Equity [Abstract]

Treasury Stock

Treasury Stock

On March 4, 2022, our Board of Directors authorized the repurchase by us of up to an aggregate of $300.0 million of our common stock by various means from time to time through and including December 31, 2026. We did not repurchase any shares of our common stock pursuant to this authorization during the three months ended March 31, 2022.

During the first three months of 2022, we issued 667,004 treasury shares which had an average cost of $3.19 per share for restricted stock units that vested during the period. In accordance with the Silgan Holdings Inc. Amended and Restated 2004 Stock Incentive Plan, we repurchased 276,826 shares of our common stock at an average cost of $41.45 to satisfy minimum employee withholding tax requirements resulting from the vesting of such restricted stock units.

We account for treasury shares using the first-in, first-out (FIFO) cost method. As of March 31, 2022, 64,312,089 shares of our common stock were held in treasury.

XML

Stock-Based Compensation	3 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based CompensationWe currently have one stock-based compensation plan in effect under which we have issued options and restricted stock units to our officers, other key employees and outside directors. During the first three months of 2022, 409,900 restricted stock units were granted to certain of our officers and other key employees. The fair value of these restricted stock units at the grant date was $17.0 million, which is being amortized ratably over the respective vesting period from the grant date.

XML

Segment Information

3 Months Ended

Mar. 31, 2022

Segment Reporting [Abstract]

Segment Information

Segment Information

Reportable segment information for the three months ended March 31 was as follows:

	Dispensing and Specialty Closures		Metal Containers		Custom Containers		Corporate		Total
	(Dollars in thousands)
Three Months Ended March 31, 2022
Net sales	$	597,927	$	650,726	$	193,233	$	—	$	1,441,886
Depreciation and amortization(1)	36,619		21,064		9,883		42		67,608
Rationalization charges	—		1,274		105		—		1,379
Segment income	87,313		38,009		24,694		(6,624)		143,392
Three Months Ended March 31, 2021
Net sales	$	509,352	$	554,081	$	174,677	$	—	$	1,238,110
Depreciation and amortization(1)	28,890		21,249		9,373		39		59,551
Rationalization charges	5,231		5,021		105		—		10,357
Segment income	65,645		45,614		24,486		(9,196)		126,549

_____________

(1)Depreciation and amortization excludes amortization of debt discount and debt issuance costs of $1.5 million and $1.3 million for the three months ended March 31, 2022 and 2021, respectively.

Total segment income is reconciled to income before income taxes for the three months ended March 31 as follows:

	2022		2021
	(Dollars in thousands)
Total segment income	$	143,392	$	126,549
Interest and other debt expense	30,830		27,306
Income before income taxes	$	112,562	$	99,243

Sales and segment income of our metal containers segment and of part of our dispensing and specialty closures segment are dependent, in part, upon the vegetable and fruit harvests in the United States and, to a lesser extent, in a variety of national growing regions in Europe. The size and quality of these harvests varies from year to year, depending in large part upon the weather conditions in applicable regions. Because of the seasonality of the harvests, we have historically experienced higher unit sales volume in the third quarter of our fiscal year and generated a disproportionate amount of our annual segment income during that quarter.

XML

Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2022

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation. The accompanying unaudited condensed consolidated financial statements of Silgan Holdings Inc., or Silgan, have been prepared in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the accompanying financial statements include all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation. The results of operations for any interim period are not necessarily indicative of the results of operations for the full year.

The Condensed Consolidated Balance Sheet at December 31, 2021 has been derived from our audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.

You should read the accompanying condensed consolidated financial statements in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2021.

XML

Revenue (Tables)

3 Months Ended

Mar. 31, 2022

Revenue Recognition [Abstract]

Disaggregation of Revenue

Revenues by segment for the three months ended March 31 were as follows:

	2022		2021
	(Dollars in thousands)
Dispensing and Specialty Closures	$	597,927	$	509,352
Metal Containers	650,726		554,081
Custom Containers	193,233		174,677
	$	1,441,886	$	1,238,110

Revenues by geography for the three months ended March 31 were as follows:

	2022		2021
	(Dollars in thousands)
North America	$	1,086,224	$	898,402
Europe and other	355,662		339,708
	$	1,441,886	$	1,238,110

XML

Rationalization Charges (Tables)

3 Months Ended

Mar. 31, 2022

Restructuring and Related Activities [Abstract]

Activity in Rationalization Plan Reserves

Rationalization charges by segment for the three months ended March 31 were as follows:

	2022		2021
	(Dollars in thousands)
Dispensing and Specialty Closures	$	—	$	5,231
Metal Containers	1,274		5,021
Custom Containers	105		105
	$	1,379	$	10,357

Activity in reserves for our rationalization plans were as follows:

	Employee Severance and Benefits		Plant Exit Costs		Non-Cash Asset Write-Down		Total
	(Dollars in thousands)
Balance at December 31, 2021	$	41,090	$	157	$	—	$	41,247
Charged to expense	621		733		25		1,379
Utilized and currency translation	(1,839)		(702)		(25)		(2,566)
Balance at March 31, 2022	$	39,872	$	188	$	—	$	40,060

XML

Accumulated Other Comprehensive Loss (Tables)

3 Months Ended

Mar. 31, 2022

Equity [Abstract]

Amounts Included in Accumulated Other Comprehensive Loss, Net of Tax

Amounts included in accumulated other comprehensive loss, net of tax, were as follows: 

	Unrecognized Net Defined Benefit Plan Costs		Change in Fair Value of Derivatives		Foreign Currency Translation		Total
	(Dollars in thousands)
Balance at December 31, 2021	$	(119,474)	$	(2,327)	$	(138,027)	$	(259,828)
Other comprehensive income before reclassifications	—		2,018		12,350		14,368
Amounts reclassified from accumulated other     comprehensive loss	499		319		—		818
Other comprehensive income	499		2,337		12,350		15,186
Balance at March 31, 2022	$	(118,975)	$	10	$	(125,677)	$	(244,642)

XML

Inventories (Tables)

3 Months Ended

Mar. 31, 2022

Inventory Disclosure [Abstract]

Inventories

Inventories consisted of the following: 

	March 31, 2022		March 31, 2021		Dec. 31, 2021
	(Dollars in thousands)
Raw materials	$	295,713	$	263,580	$	394,102
Work-in-process	263,878		167,137		157,406
Finished goods	607,087		452,553		394,378
Other	14,787		14,955		15,731
	1,181,465		898,225		961,617
Adjustment to value inventory at cost on the LIFO method	(162,780)		(109,588)		(162,780)
	$	1,018,685	$	788,637	$	798,837

XML

Long-Term Debt (Tables)

3 Months Ended

Mar. 31, 2022

Debt Disclosure [Abstract]

Long-term Debt

Long-term debt consisted of the following: 

	March 31, 2022		March 31, 2021		Dec. 31, 2021
	(Dollars in thousands)
Bank debt
Bank revolving loans	$	508,000	$	137,000	$	—
U.S. term loans	1,000,000		400,000		1,000,000
Other foreign bank revolving and term loans	50,014		60,030		38,862
Total bank debt	1,558,014		597,030		1,038,862
4¾% Senior Notes	—		300,000		300,000
3¼% Senior Notes	723,190		763,945		739,180
4⅛% Senior Notes	600,000		600,000		600,000
2¼% Senior Notes	556,300		587,650		568,600
1.4% Senior Secured Notes	500,000		500,000		500,000
Finance leases	67,714		33,936		68,730
Total debt - principal	4,005,218		3,382,561		3,815,372
Less unamortized debt issuance costs and debt discount	20,451		24,147		22,195
Total debt	3,984,767		3,358,414		3,793,177
Less current portion	539,134		195,122		20,251
	$	3,445,633	$	3,163,292	$	3,772,926

XML

Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2022

Investments, All Other Investments [Abstract]

Summary of Carrying Amounts and Estimated Fair Values of Other Financial Instruments

The following table summarizes the carrying amounts and estimated fair values of our other financial instruments at March 31, 2022:

	Carrying Amount		Fair Value
	(Dollars in thousands)
Assets:
Cash and cash equivalents	$	259,564	$	259,564
Liabilities:
Bank debt	$	1,558,014	$	1,558,014
3¼% Senior Notes	723,190		721,671
4⅛% Senior Notes	599,229		575,280
2¼% Senior Notes	556,300		507,624
1.4% Senior Secured Notes	499,784		456,550

XML

Retirement Benefits (Tables)

3 Months Ended

Mar. 31, 2022

Retirement Benefits [Abstract]

Components of Net Periodic Benefit Cost

The components of the net periodic pension benefit credit for the three months ended March 31 were as follows:

	2022		2021
	(Dollars in thousands)
Service cost	$	3,300	$	3,788
Interest cost	5,159		4,354
Expected return on plan assets	(17,314)		(19,848)
Amortization of prior service cost	55		58
Amortization of actuarial losses	1,155		3,026
Net periodic benefit credit	$	(7,645)	$	(8,622)

The components of the net periodic other postretirement benefit credit for the three months ended March 31 were as follows:

	2022		2021
	(Dollars in thousands)
Service cost	$	25	$	28
Interest cost	109		95
Amortization of prior service credit	(416)		(456)
Amortization of actuarial gains	(77)		(48)
Net periodic benefit credit	$	(359)	$	(381)

XML

Segment Information (Tables)

3 Months Ended

Mar. 31, 2022

Segment Reporting [Abstract]

Reportable Operating Segment Information

Reportable segment information for the three months ended March 31 was as follows:

	Dispensing and Specialty Closures		Metal Containers		Custom Containers		Corporate		Total
	(Dollars in thousands)
Three Months Ended March 31, 2022
Net sales	$	597,927	$	650,726	$	193,233	$	—	$	1,441,886
Depreciation and amortization(1)	36,619		21,064		9,883		42		67,608
Rationalization charges	—		1,274		105		—		1,379
Segment income	87,313		38,009		24,694		(6,624)		143,392
Three Months Ended March 31, 2021
Net sales	$	509,352	$	554,081	$	174,677	$	—	$	1,238,110
Depreciation and amortization(1)	28,890		21,249		9,373		39		59,551
Rationalization charges	5,231		5,021		105		—		10,357
Segment income	65,645		45,614		24,486		(9,196)		126,549

_____________

(1)Depreciation and amortization excludes amortization of debt discount and debt issuance costs of $1.5 million and $1.3 million for the three months ended March 31, 2022 and 2021, respectively.

Reconciliation of Segment Income from Operations to Income before Income Taxes

Total segment income is reconciled to income before income taxes for the three months ended March 31 as follows:

	2022		2021
	(Dollars in thousands)
Total segment income	$	143,392	$	126,549
Interest and other debt expense	30,830		27,306
Income before income taxes	$	112,562	$	99,243

XML

Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Segment Reporting Information [Line Items]
Net sales	$ 1,441,886	$ 1,238,110
Trade Accounts Receivable | Unbilled Accounts Receivable
Segment Reporting Information [Line Items]
Contract assets	99,100	86,400	$ 78,200
North America
Segment Reporting Information [Line Items]
Net sales	1,086,224	898,402
Europe and other
Segment Reporting Information [Line Items]
Net sales	355,662	339,708
Dispensing and Specialty Closures
Segment Reporting Information [Line Items]
Net sales	597,927	509,352
Metal Containers
Segment Reporting Information [Line Items]
Net sales	650,726	554,081
Custom Containers
Segment Reporting Information [Line Items]
Net sales	$ 193,233	$ 174,677

XML

Rationalization Charges - Rationalization Charges by Business Segment (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Restructuring Cost and Reserve [Line Items]
Rationalization charges	$ 1,379	$ 10,357
Dispensing and Specialty Closures
Restructuring Cost and Reserve [Line Items]
Rationalization charges	0	5,231
Metal Containers
Restructuring Cost and Reserve [Line Items]
Rationalization charges	1,274	5,021
Custom Containers
Restructuring Cost and Reserve [Line Items]
Rationalization charges	$ 105	$ 105

XML

Rationalization Charges - Activity in Rationalization Plan Reserves (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Restructuring Reserve [Roll Forward]
Balance at December 31, 2021	$ 41,247
Charged to expense	1,379	$ 10,357
Utilized and currency translation	(2,566)
Balance at March 31, 2022	40,060
Employee Severance and Benefits
Restructuring Reserve [Roll Forward]
Balance at December 31, 2021	41,090
Charged to expense	621
Utilized and currency translation	(1,839)
Balance at March 31, 2022	39,872
Plant Exit Costs
Restructuring Reserve [Roll Forward]
Balance at December 31, 2021	157
Charged to expense	733
Utilized and currency translation	(702)
Balance at March 31, 2022	188
Non-Cash Asset Write-Down
Restructuring Reserve [Roll Forward]
Balance at December 31, 2021	0
Charged to expense	25
Utilized and currency translation	(25)
Balance at March 31, 2022	$ 0

XML

Rationalization Charges - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Restructuring Cost and Reserve [Line Items]
Restructuring reserve	$ 40,060	$ 41,247
Other Restructuring | Rationalization Plan
Restructuring Cost and Reserve [Line Items]
Remaining expenses	600
Remaining cash expenditures	2,200
Annually Through 2040 | Central States Pension Plan withdrawal
Restructuring Cost and Reserve [Line Items]
Remaining cash expenditures	3,100
Accretion expense	1,000
Accrued Liabilities
Restructuring Cost and Reserve [Line Items]
Restructuring reserve	4,800
Other Liabilities
Restructuring Cost and Reserve [Line Items]
Restructuring reserve	$ 35,300

XML

Accumulated Other Comprehensive Loss - Amounts Included in Accumulated Other Comprehensive Loss, Net of Tax (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance	$ 1,562,696
Other comprehensive income before reclassifications	14,368
Amounts reclassified from accumulated other comprehensive loss	818
Other comprehensive income (loss)	15,186	$ (30,853)
Ending balance	1,638,239	1,276,356
Accumulated Other Comprehensive Loss
Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance	(259,828)	(260,953)
Ending balance	(244,642)	$ (291,806)
Unrecognized Net Defined Benefit Plan Costs
Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance	(119,474)
Other comprehensive income before reclassifications	0
Amounts reclassified from accumulated other comprehensive loss	499
Other comprehensive income (loss)	499
Ending balance	(118,975)
Change in Fair Value of Derivatives
Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance	(2,327)
Other comprehensive income before reclassifications	2,018
Amounts reclassified from accumulated other comprehensive loss	319
Other comprehensive income (loss)	2,337
Ending balance	10
Foreign Currency Translation
Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance	(138,027)
Other comprehensive income before reclassifications	12,350
Amounts reclassified from accumulated other comprehensive loss	0
Other comprehensive income (loss)	12,350
Ending balance	$ (125,677)

XML

Accumulated Other Comprehensive Loss - Additional Information (Details) $ in Millions	3 Months Ended
	Mar. 31, 2022 USD ($)
Unrecognized Net Defined Benefit Plan Costs
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive (loss) reclassification adjustment from AOCI	$ (0.7)
Benefit for income taxes	0.2
Amortization of net actuarial (losses), before tax	(1.1)
Net prior service credit arising during period, before tax	0.4
Accumulated Translation Adjustment
Accumulated Other Comprehensive Income (Loss) [Line Items]
Foreign currency gains (losses)	3.0
Foreign currency transaction and translation gain (loss) arising during period related to intra-entity transactions of a long-term investment nature, net of tax	0.8
Foreign currency (losses) gains of net investment hedges included in accumulated other comprehensive loss	11.3
Foreign currency translation, tax benefit (provision) related to net investment hedges	$ (2.7)

XML

Inventories (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021
Inventory Disclosure [Abstract]
Raw materials	$ 295,713	$ 394,102	$ 263,580
Work-in-process	263,878	157,406	167,137
Finished goods	607,087	394,378	452,553
Other	14,787	15,731	14,955
Inventories, gross	1,181,465	961,617	898,225
Adjustment to value inventory at cost on the LIFO method	(162,780)	(162,780)	(109,588)
Inventories	$ 1,018,685	$ 798,837	$ 788,637

XML

Long-Term Debt - Schedule of Long-term Debt (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021
Debt Instrument [Line Items]
Total debt - principal	$ 4,005,218	$ 3,815,372	$ 3,382,561
Less unamortized debt issuance costs and debt discount	20,451	22,195	24,147
Debt long term and short term less unamortized debt issuance costs and debt discount	3,984,767	3,793,177	3,358,414
Less current portion	539,134	20,251	195,122
Long-term debt	3,445,633	3,772,926	3,163,292
Bank debt
Debt Instrument [Line Items]
Total debt - principal	1,558,014	1,038,862	597,030
Finance Leases
Debt Instrument [Line Items]
Total debt - principal	67,714	68,730	33,936
Bank Revolving Loans | Bank debt
Debt Instrument [Line Items]
Total debt - principal	508,000	0	137,000
Less current portion	508,000
U S Term Loans | Bank debt
Debt Instrument [Line Items]
Total debt - principal	1,000,000	1,000,000	400,000
Other Foreign Bank Revolving and Term Loans | Bank debt
Debt Instrument [Line Items]
Total debt - principal	50,014	38,862	60,030
Less current portion	28,400
Senior Notes | 4¾% Notes
Debt Instrument [Line Items]
Total debt - principal	$ 0	300,000	300,000
Senior note interest rate	4.75%
Senior Notes | 3¼% Senior Notes
Debt Instrument [Line Items]
Total debt - principal	$ 723,190	739,180	763,945
Senior note interest rate	3.25%
Senior Notes | 4⅛% Senior Notes
Debt Instrument [Line Items]
Total debt - principal	$ 600,000	600,000	600,000
Senior note interest rate	4.125%
Senior Notes | 2¼% Senior Notes
Debt Instrument [Line Items]
Total debt - principal	$ 556,300	568,600	587,650
Senior note interest rate	2.25%
Senior Notes | 1.4% Senior Secured Notes
Debt Instrument [Line Items]
Total debt - principal	$ 500,000	$ 500,000	$ 500,000
Senior note interest rate	1.40%
Finance Leases
Debt Instrument [Line Items]
Less current portion	$ 2,700

XML

Long-Term Debt - Narrative (Details) - USD ($)		3 Months Ended
	Mar. 28, 2022	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Debt Instrument [Line Items]
Long-term debt, current maturities		$ 539,134,000	$ 195,122,000	$ 20,251,000
Loss on early extinguishment of debt		1,481,000	$ 883,000
Finance Leases
Debt Instrument [Line Items]
Long-term debt, current maturities		2,700,000
Bank debt | Bank Revolving Loans
Debt Instrument [Line Items]
Long-term debt, current maturities		508,000,000
Bank debt | Other Foreign Bank Revolving and Term Loans
Debt Instrument [Line Items]
Long-term debt, current maturities		28,400,000
Four and Three Quarters Percent Senior Notes due 2025 [Member] | Senior Notes
Debt Instrument [Line Items]
Early repayment of senior debt	$ 300,000,000
Debt instrument, redemption price (in percentage)	100.00%
Loss on early extinguishment of debt		$ 1,500,000

XML

Financial Instruments - Carrying Amounts and Estimated Fair Values of Other Financial Instruments (Details) $ in Thousands	Mar. 31, 2022 USD ($)
Senior Notes | 3¼% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior note interest rate	3.25%
Senior Notes | 4⅛% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior note interest rate	4.125%
Senior Notes | 2¼% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior note interest rate	2.25%
Senior Notes | 1.4% Senior Secured Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior note interest rate	1.40%
Carrying Amount
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	$ 259,564
Carrying Amount | Bank debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Bank debt	1,558,014
Carrying Amount | Senior Notes | 3¼% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Bank debt	723,190
Carrying Amount | Senior Notes | 4⅛% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Bank debt	599,229
Carrying Amount | Senior Notes | 2¼% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Bank debt	556,300
Carrying Amount | Senior Notes | 1.4% Senior Secured Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Bank debt	499,784
Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	259,564
Fair Value | Bank debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Bank debt	1,558,014
Fair Value | Senior Notes | 3¼% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Bank debt	721,671
Fair Value | Senior Notes | 4⅛% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Bank debt	575,280
Fair Value | Senior Notes | 2¼% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Bank debt	507,624
Fair Value | Senior Notes | 1.4% Senior Secured Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Bank debt	$ 456,550

XML

Financial Instruments - Additional Information (Details)	3 Months Ended
	Mar. 31, 2022 USD ($)
USD Interest Rate Swap Contract One
Derivative [Line Items]
Derivative, notional amount	$ 50,000,000
Fixed interest rate	2.878%
USD Interest Rate Swap Contract Two
Derivative [Line Items]
Derivative, notional amount	$ 50,000,000
Fixed interest rate	2.878%
Accumulated Translation Adjustment
Derivative [Line Items]
Foreign currency (losses) gains of net investment hedges included in accumulated other comprehensive loss	$ 11,300,000

XML

Retirement Benefits - Components of Net Periodic Benefit Cost (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Pension Benefit Plans
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 3,300	$ 3,788
Interest cost	5,159	4,354
Expected return on plan assets	(17,314)	(19,848)
Amortization of prior service cost	55	58
Amortization of actuarial losses	1,155	3,026
Net periodic benefit credit	(7,645)	(8,622)
Other Postretirement Benefit Plans, Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Service cost	25	28
Interest cost	109	95
Amortization of prior service cost	(416)	(456)
Amortization of actuarial losses	(77)	(48)
Net periodic benefit credit	$ (359)	$ (381)

XML

Treasury Stock - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 04, 2022
Equity, Class of Treasury Stock [Line Items]
Treasury stock (in shares)	64,312,089
2022 BOD Authorized Common Stock Repurchase
Equity, Class of Treasury Stock [Line Items]
Stock repurchase program, additional repurchase authorization		$ 300,000,000.0
2004 Amended and Restated Stock Incentive Plan
Equity, Class of Treasury Stock [Line Items]
Treasury shares issued for restricted stock units that vested during the period (in shares)	667,004
Average cost of treasury shares that were issued for restricted stock units that vested during the period (usd per share)	$ 3.19
Shares repurchased to satisfy minimum employee withholding tax requirements resulting from the vesting of such restricted stock units (in shares)	276,826
Average cost per share of treasury stock acquired (usd per share)	$ 41.45

XML

Stock-Based Compensation - Additional Information (Details) - Restricted Stock Units $ in Millions	3 Months Ended
	Mar. 31, 2022 USD ($) shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock units granted (in shares) | shares	409,900
Fair value of restricted stock units granted | $	$ 17.0

XML

Segment Information - Reportable Business Segment Information (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2022	Mar. 31, 2021
Segment Reporting Information [Line Items]
Net sales		$ 1,441,886	$ 1,238,110
Depreciation and amortization	[1]	67,608	59,551
Rationalization charges		1,379	10,357
Segment income		143,392	126,549
Amortization of debt issuance costs and discounts		1,500	1,300
Dispensing and Specialty Closures
Segment Reporting Information [Line Items]
Net sales		597,927	509,352
Depreciation and amortization	[1]	36,619	28,890
Rationalization charges		0	5,231
Segment income		87,313	65,645
Metal Containers
Segment Reporting Information [Line Items]
Net sales		650,726	554,081
Depreciation and amortization	[1]	21,064	21,249
Rationalization charges		1,274	5,021
Segment income		38,009	45,614
Custom Containers
Segment Reporting Information [Line Items]
Net sales		193,233	174,677
Depreciation and amortization	[1]	9,883	9,373
Rationalization charges		105	105
Segment income		24,694	24,486
Corporate
Segment Reporting Information [Line Items]
Net sales		0	0
Depreciation and amortization	[1]	42	39
Rationalization charges		0	0
Segment income		$ (6,624)	$ (9,196)

[1] Depreciation and amortization excludes amortization of debt discount and debt issuance costs of $1.5 million and $1.3 million for the three months ended March 31, 2022 and 2021, respectively.

XML

Segment Information - Reconciliation of Segment Income to Income before Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Segment Reporting [Abstract]
Segment income	$ 143,392	$ 126,549
Interest and other debt expense	30,830	27,306
Income before income taxes	$ 112,562	$ 99,243